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The goal of this thesis was to define the contribution of lymphocyte receptor diversity to the 
functions that define adaptive immunity. Most in the field of immunology believe that immune 
fitness requires lymphocyte receptor diversity. In models of contracted lymphocyte diversity, we 
tested this idea.  We tested the fitness of cell-mediated immunity in mice with contracted T cell 
diversity and we tested the impact of contracted T cell receptor diversity on the generation of B 
cell responses to model antigens. 





 mice that lack
 
B cells and have TCR V  diversity < 1 % that of wild-type mice
 
and 
QuasiMonoclonal (QM) mice with oligoclonal B cells and TCR
 
V  diversity 7 % that of wild-
type mice. Despite having a TCR
 





 mice rejected H-Y-incompatible skin grafts
 





T cell priming by peptide and delayed-type hypersensitivity,
 
although these 
responses were less than normal owing either
 
to TCR repertoire contraction or defective 
lymphoid organogenesis.
 
QM mice with TCR diversity contracted > 90 %, and normal lymphoid
 
organs rejected H-Y incompatible skin grafts as rapidly as wild
 
type mice and exhibited normal T 
cell priming and normal delayed-type
 
hypersensitivity reactions. QM mice also resisted 
Pneumocystis
 
murina like wild-type mice. Thus, cell-mediated immunity can
 
function normally 
despite contractions of TCR diversity > 90 %
 
and possibly > 99 %.  Our results showed that 
many of the responses attributed to T cells appear to be independent of TCR diversity.   
In search for an adaptive advantage of receptor diversity, we asked whether contractions of T cell 
receptor diversity impaired B cell responses and the generation of high affinity antibodies.   
Contrary to the prediction of that in mature individuals the generation of B-cell memory would 
proceed independently of the thymus, we show here that removal of the thymus after the 
establishment of the T-cell compartment or sham surgery without removal of the thymus impairs 
the affinity maturation of antibodies.  Because removal or manipulation of the thymus did not 
decrease the frequency of mutation of the Ig variable heavy chain exons encoding antigen-
specific antibodies, we conclude that the thymus controls affinity maturation of antibodies in the 
mature individual by facilitating selection of B cells with high affinity antibodies. 
 




Cílem disertační práce bylo definovat podíl diverzity receptorů pro antigen na funkcích, které 
určují adaptivní imunitu. Obvykle se předpokládá, že imunologická způsobilost vyžaduje 
diverzitu lymfocytárních receptorů. My jsme tuto hypotézu ověřili na modelu omezené 
lymfocytární diverzity. Byla testována způsobilost buňkami zprostředkované imunity myší 
s omezenou diverzitou receptorů TCR. Byl ověřen vliv omezené diverzity receptorů TCR na 
vznik B lymfocytární odpovědi indukované modelovými antigeny.  
Koncept způsobilosti buňkami zprostředkované imunity ve vazbě na diverzitu receptorů PCR byl 
ověřen na myších  experimentálních modelech, který zahrnovaly myši JH
-/-
, u kterých nejsou 
vyvinuty B lymfocyty a mají diverzitu receptorů TCR < 1 %, kmen konvenčních myší a 
quasimonoklonální (QM) myši s oligoklonální B lymfocytární populací a diverzitou oblastí V 
TCR receptorů 7 % v porovnání s konvenčním kmenem. V experimentech jsme zjistili, že myši 
JH
-/-
 odhojují H-Y inkompatibilní kožní štěpy stejně rychle jako konvenční kmen myší, přestože 
mají omezený repertoár TCR receptor > 99 % a projevují známky defektní organogeneze 
lymfoidních orgánů. Myši JH
-/-
 reagují  aktivací T lymfocytů po stimulaci peptidem a vykazují 
opožděný typ hypersenzitivity, přestože intenzita těchto reakcí je nižší než u konvenčních myší, 
buď jako důsledek omezeného repertoáru TCR nebo defektní organogeneze lymfoidních orgánů. 
Myši QM s repertoárem TCR omezeným na > 90 % a normálním vývojem lymfoidních orgánů, 
odhojují H-Y inkopatibilní kožní štěpy srovnatelně s konvenčním kmenem myší a mají 
zachovanou schopnost aktivace T lymfocytů i opožděné hypersenzitivní reakce. Myši QM jsou 
také odolné vůči infekci Pneumocystis murina v míře srovnatelné s konvenčním kmenem myší. 
Lze tedy uzavřít, že buňkami zprostředkovaná imunita u myší JH 
-/-
 a QM myší vykazuje 
normální funkce, přestože je diverzita receptorů TCR je omezena na > 99 % a > 90 %. Naše 
výsledky ukázaly, že mnohé z aktivit připisovaných T lymfocytům se jeví být nezávislé na 
diverzitě receptorů TCR.  
S cílem ověřit adaptivní výhody diverzity receptoru pro antigen, jsme ověřili hypotézu, zda 
omezení repertoáru TCR receptorů negativně ovlivní B lymfocytární odpověď a tvorbu 
vysokoafinních protilátek. V protikladu vůči předpokladu, že u dospělých jedinců probíhá vznik 
paměťových B lymfocytů nezávisle na thymu, prokázali jsme experimentálně, že odstranění 
thymu po ustavení T lymfocytárního kompartmentu nebo po „sham― operaci bez odstranění 
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thymu negativně ovlivní afinitní vyzrávání protilátek. Protože odstranění nebo manipulace 
s thymem nesnižuje frekvenci mutací v exonech kódujících variabilní část molekuly protilátek 
specifických pro antigen, uzavíráme, že thymus kontroluje afinitní vyzrávání protilátek u 
dospělých jedinců mechanismem usnadnění selekce klonů B lymfocytů se schopností produkovat 
vysokoafinní protilátky. 
 



















ASC   Antibody secreting cells 
CD   Cluster designation 
CDR3  Complementarity determining region 3 
CI   Confidence interval 
DTH  Delayed type hypersensitivity 
ELISA  Enzyme-linked immunosorbent assay 
IGMT   ImMunoGeneTics information system 
IL   Interleukin 
PADRE  Pan DR reactive epitope 
QM  Quasi monoclonal 
SD   Standard deviation 
TNF   Tumor necrosis factor 
TLR   Toll-like receptor 









The immune system is the body defense mechanism. It acts by responding to any offending 
agent. This consists of a series of molecular and cellular events that lead to contain the 
aggravating agent. This agent usually is a pathologic organism, toxic substance, cellular debris or 
tumor cell.  
Traditionally, the immune system divided in to two categories: innate and adaptive. The innate 
immune system responds to offending agent without specialized recognitions or previous 
encounter. The adaptive immune system is more sophisticated in with it requires recognition 
from previous encounter to mount an immune response.  
Immune responses: 
1. Innate immunity characterized by having a preset very standardized method of 
responding to offending agent that is recognized in antigen-independent matter. 
This reaction leads to the production and release of cytokines and mediators to 
attach the offending agent. Cells involved in this reaction include neutrophils and 
macrophages (Delves and Roitt 2006).  
2. Adaptive immunity in the other hand needs a specific antigen to be activated to 
generate a response. This mechanism is carried on by the antigen specific effector 
cells (B-cell, T-cells). The first step is to recognize the foreign material and 
ensure that it is not-self.  Then it gets broken to unique antigenes that are 
recognized by the immune effector cells and the processes of elimination or 
isolation starts (Delves and Roitt 2006). 
One of the important features of the adaptive immune system is that it is adaptive. After 
eliminating self-reacting cells during the early development (Male 1996), it starts generating 
cells with receptors reactive against new unrecognized molecular structure. In this process 
antigen specific T cells and antigen specific antibodies are produced.  
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This system is contently evolving as it encounters new antigens. B cells do that by 
recombination, rearrangement and mutation of the naive gene (Lim et al. 2008; Schatz et al. 
1989). This allows this system to have very large repertoire of receptors that potentially could 
recognize a huge number of antigens (Oettinger et al. 1990).  
In this review, we will focus on the adaptive system component and function.  The mechanism of 
function of the system, is thought to be triggered by antigens. This mostly proteins but could be 
lipids or carbohydrates(Bollum 1978). As we described earlier this response is mediated by 
specific T-cell and B- cells. These cells have antigen receptors (paratopes) that is presented in the 
T lymphocytes or on antibodies produced by B cells. These receptors are specific for each 
antigen segment (epitope). This series of reaction (recognition, processing and responding) 
explain the delay in the adaptive immune response. One of the hallmarks of adaptive immune 
system that it utilizes memory to previous encounter. This leads to stronger, faster secondary 
response to the same offender. 
The mechanism of action of the adaptive immune system can be divided to three stages. In the 
first stage the offending molecule encounter antigen presenting cells and interaction occur. This 
then lead to processing of the offending molecule antigen and then presents it to (T cells, B cells, 
antibodies). The antigen presenting cells encounter the antigen at different sites then it migrates 
through lymphatics to lymph nodes. Then the effector cells and antibody’s migrate to primary 
site of encounter to form immune complex or delayed hypersensitivity reaction.  
B lymphocytes main function is the production of antibodies after getting activated by helper T 
lymphocytes. Antibodies are molecules that have a specific receptor for one antigen epitope and 
they are made of glycoproteins. Majority of B cells start as naïve lymphocytes.  A certain 
population of B cells functions as an antigen presenting cells. They express IgM and IgD on their 
surface that functions as antigen receptor that recognizes antigen epitope. At this point helper T 
cell interacts with B cells leading to farther activation and differentiation. This include but not 
limited to cell division, synthesize and release antibody’s, expressing of accessory molecules and 
change the antibody class from IgM to IgG, IgA or IgE (Gilfillan et al. 1993; Honjo et al. 2002; 




Classical teaching of T cells function stress that helper T cells are the main functional cell type 
for immune processing. CD4 is expressed on most helper T lymphocyte cell membrane.  T cells 
recognize antigens only when it is presented on APC with HLA molecule after it have been 
processed. When this complex bind to antigen receptor on T lymphocyte, CD4 molecule function 
both, as a bond stabilizer and a signal enhancer. This leads to T cell activation and release 
cytokines in addition to cell division and expression cell adhesion molecule and costimulatory 
molecules. The release of IL-2 by this mechanism is an important factor in the progression of T 
cell activation and functional differentiation.  
In Summary, the adaptive immune system of higher vertebrates has two distinguishing 
properties.  These properties are specificity, and memory.  Adaptive immunity has the ability of 
mounting responses to disparate molecules in part due to the great diversity of lymphoid 
receptors which in humans exceed 10 million.  Responses that result from engaging one receptor 
with one ligand are generally specific to that pair of ligand and receptor. Once a productive 
response has been generated, subsequent responses directed at the same antigen will develop 
faster and with increased efficiency enhancing protection of the host.  These properties are often 
referred to as memory. The goal of my thesis was to define the contribution of lymphocyte 
receptor diversity to the functions that define adaptive immunity. 
Most in the field of immunology believe that immune fitness requires lymphocyte receptor 
diversity (Thompson and Neiman 1987; Yoshikawa et al. 2002).  In models of contracted 
lymphocyte diversity we tested this idea.  In Chapter 3 I tested the fitness of cell mediated 
immunity in mice with contracted T cell diversity and in Chapter 4 I tested the impact of 
contracted T cell receptor diversity on the generation of B cell responses to model antigens 
(Tuaillon and Capra 2000). 
 Fitness of cell-mediated immunity is thought to depend on TCR
 
diversity (Cabaniols et al. 
2001); however, this concept has not been tested formally.
 





B cells and have TCR V  diversity  < 1 % that of wild-type mice
 
and 
QuasiMonoclonal (QM) mice with oligoclonal B cells and TCR
 
V  diversity 7 % that of wild-
type mice. Despite having a TCR
 





 mice rejected H-Y-incompatible skin grafts
 





T cell priming by peptide and delayed-type hypersensitivity,
 
although these 
responses were less than normal owing either
 





QM mice with TCR diversity contracted > 90 %, and normal lymphoid
 
organs rejected H-Y incompatible skin grafts as rapidly as wild
 
type mice and exhibited normal T 
cell priming and normal delayed-type
 
hypersensitivity reactions. QM mice also resisted 
Pneumocystis
 
murina like wild-type mice. Thus, cell-mediated immunity can
 
function normally 
despite contractions of TCR diversity > 90 %
 
and possibly > 99 %.  Our results showed that 
many of the responses attributed to T cells appear to be independent of TCR diversity.  In search 
for an adaptive advantage of receptor diversity we asked whether contractions of T cell receptor 
diversity impaired B cell responses and the generation of high affinity antibodies.   
The generation of B-cell responses to proteins requires a functional thymus to produce CD4
+
 T 
cells which help in the activation and differentiation of B cells.  Because the mature T-cell 
repertoire has abundant cells with the helper phenotype, one might predict that in mature 
individuals the generation of B-cell memory would proceed independently of the thymus.  
Contrary to that prediction, we show here that removal of the thymus after the establishment of 
the T-cell compartment or sham surgery without removal of the thymus impairs the affinity 
maturation of antibodies.  Because removal or manipulation of the thymus did not decrease the 
frequency of mutation of the Ig variable heavy chain exons encoding antigen-specific antibodies, 
we conclude that the thymus controls affinity maturation of antibodies in the mature individual 










OBJECTIVES OF THE THESIS 
 
Specific Aim 1: To determine what mechanisms maintain the number and diversity of T cells in 
the peripheral T cell compartment.  
Rationale: Our lab recently found that TCR diversification in the thymus depends on B cell 
receptor or immunoglobulin (lg) diversity. We also found that B cells help maintain the number 
and diversity of T cells in the peripheral T cell compartment. We will determine the extent to 
which thymus output, peripheral survival or proliferation maintain the size and diversity of the T 
cell compartment.  
 
Specific Aim 2: To determine how the T cell compartment adapts to contraction of T cell 
diversity.  
Rationale: We found that when T cell diversity is contracted, T cells commonly exhibit a 
"memory-like" phenotype; the functional significance of this phenotype in this setting is 
unknown. We will determine whether the T cells in mice with contracted T cell diversity exhibit 
memory-like function, and/or whether the cells cross-react more widely than normal T cells 
and/or immune-regulation is modified in this setting.  
 
Specific Aim 3: To determine which functions of cell-mediated immunity are impaired by 
contraction of T cell diversity.  
Rationale: We have found that human subjects and mice with profoundly decreased T cell 
diversity can reject allografts, even across minor antigen barriers, mount normal primary immune 
responses and avoid the opportunistic infections characteristic of DiGeorge syndrome and AIDS. 
Still these individuals have higher levels of gamma herpes viruses (in the case of humans) and 
Pneumocystis murinae (in the case of mice) than do normal individuals. We will test whether 
mice with severe contraction of T cell diversity can clear pathogenic microorganisms and 
whether these organisms cause disease, as opposed to modifying endogenous levels without 





Specific Aim 4:  To determine how thymectomy, T cell depletion and immunosuppression in 
mice, separately or in combination, compromise B cell memory responses.  
Rationale: Postnatal thymectomy of mice, at 5 weeks decreases persistently the number of CD4 
and CD8 T cells while maintaining the number of B cells in the periphery. 
We performed thymectomy in C57BL/6 mice at 5 weeks of age. Thymectomy effectively 
abrogated thymic function because thymectomized mice lacked any measurable T cell receptor 
excision circles. 
To determine if thymectomy perturbed the T and B cell compartments we enumerated T and B 
cells in the spleens of thymectomized, sham operated or unmanipulated mice 5 and 10 weeks 
after the operation.  We will show that postnatal thymectomy causes a persistent 4 fold decrease 
in the number of CD4- or CD8-positive T cells, while the number of B cells is maintained. Our 
results suggest that the adult thymus contributes to the maintenance of T cells in the periphery of 
mice.   
 
Specific Aim 5:  If B cell memory is maintained following thymectomy in young mice  
B cell memory antibody responses critically depend on T cell help.   
Rationale: To determine the extent to which T cell function was maintained in thymectomized 
mice we performed male to female skin grafts.  To determine whether thymectomy perturbed 
primed T cell responses we tested delayed type hypersensitivity (DTH) to ovalbumin in the 
footpad of mice.   
The median survival time of male skin grafts was 37 days in thymectomized female mice and 
only 25 days in sham operated and control mice. Thus, thymectomy impairs cellular immunity to 
minor antigens. The median survival time of secondary male skin grafts was 19 days in 
thymectomized female mice, 16 days in sham operated mice and 15 days in control mice.  Re-
transplant 30 days after shedding of the primary graft, hastened graft rejection in all mice even 
though thymectomized recipients had delayed graft rejection compared to controls. Accelerated 
secondary graft rejection indicates efficient generation of T cell memory. To test long-lived 
plasma cells we will determined the number of NP-specific antibody secreting cells in the spleen 





Specific Aim 1, 2 and 3 
B cell deficiency has been associated with defective T cell responses
 
to intracellular 
microorganisms such as Salmonella enterica
 
(Mastroeni et al. 2000), Bordetella pertussis (Elkins 
et al. 1999), Plasmodium chabaudi
 
(Langhorne et al. 1998), Chlamydia trachomatis (Yang and 
Brunham 1998), Leishmania major (Hoerauf et al. 1996), coronavirus
 
(Bergmann et al. 2001), 
and Lymphocytic choriomeningitis virus (Homann et al. 1998). Like B cell-deficient
 
mice, 
humans with X-linked agammaglobulinemia, who have very
 
few peripheral B cells and very 
reduced levels of serum Ig,
 
are highly susceptible to such organisms as mycoplasma (Minegishi 
et al. 1999),
 
enteroviruses (Minegishi, Rohrer and Conley 1999), and echoviruses (Wilfert et al. 
1977) and to the development
 
of poliomyelitis following vaccination with attenuated viruses
 
(Wright et al. 1977). Defective responses to intracellular pathogens suggest
 
the possibility that, in 
addition to hypogammaglobulinemia,
 
individuals and mice with B cell deficiency may suffer 
intrinsic
 
abnormalities in the T cell compartment. We recently found that
 
B cell-deficient mice 
have a remarkable decrease in the number
 
and diversity of thymocytes (Joao et al. 2004; 
Keshavarzi et al. 2003) and hypothesized that defects
 
in cell-mediated immunity could result 
from contraction of the
 
TCR repertoire. Because each TCR recognizes a limited number
 
of 
different peptides associated with MHC, the recognition of
 
diverse Ags, even allowing for cross-
reactivity, is thought
 
to reflect the diversity of the TCR repertoire. Thus, the competency
 
of 
cellular immunity is thought to depend on the number and
 
diversity of T cells available to mount 
a response (Nikolich-Zugich et al. 2004).
 
 
However, the concept that TCR diversity determines the competence
 
of cell-mediated immunity 
does not explain every aspect of immune
 
physiology. Although the TCR repertoire contracts 
profoundly
 
with age (Goronzy and Weyand 2005) and elderly individuals can suffer 
disseminated
 
viral infections and heightened susceptibility to tumors, most
 
elderly individuals 
experience neither of these ailments (compared
 
with those who have AIDS). Still more dramatic 
is the observation
 
that those who undergo cardiac transplantation in infancy and
 
have a profound 
contraction of the TCR repertoire owing to "total"
 
thymectomy and mature T cell depletion 
suffer no excess of opportunistic
 





We asked whether and to what extent defects in TCR diversity
 
impair cell-mediated immunity. 
Toward this end, we exploited
 
mice that, owing to defects in the assembly of Ig genes (Cascalho 
et al. 1996; Chen et al. 1993) have profoundly contracted TCR repertoires. Our results
 
indicate 
that extreme contractions of TCR repertoire do not
 
impair cell-mediated immunity and host 
defense. These unexpected
 
results have profound implications for transplantation and in
 
the 

















Specific Aim 4 and 5 
B cell memory confers lasting immunity to microorganisms and their products by ensuring rapid 
production of high affinity antibodies of switched isotype(s) (particularly immunoglobulin G 
(IgG)), distinct from those that predominate in the ―natural‖ immune response.  Antibodies 
opsonize microbes and neutralize toxins and viruses, precluding cell entry and damage.  The high 
affinity of recall antibodies may be the most critical property for effective neutralization of 
toxins since those are toxic at very low concentrations.  Production of high affinity class 
switched antibodies requires that activated B cells undergo somatic hypermutation and class 
switch recombination, followed by antigen selection of B cells expressing the receptors with 
enhanced affinity.  B cell memory is manifested by recall antibody responses the result of plasma 
cells generated from B memory cells upon re-exposure to the antigen and by persisting antigen-
specific antibodies secreted by long-lived plasma cells in the bone marrow (Manz et al. 2002).  
The generation of B cell memory requires T cells.  Thus, removal of the thymus in newborn mice 
(during the first 16 hours of life) causes severe cellular immunity defects (Miller 1961) and 
abolishes antibody responses to protein antigens (Miller et al. 1965).  However, removal of the 
thymus of mature mice (between 5 and 8 weeks of age) has no immediate effect on the primary 
antibody responses to protein antigens or cellular immune responses (Metcalf 1965; Miller 1965; 
Taylor 1965).  Whether or not removal of the thymus in mature individuals perturbs B cell 
memory is not known.  
T cells promote B cell responses to protein antigens by directly interacting with B cells.  Thus, 
deficiencies in the CD40 or CD154 or blocking their interaction by antibodies impairs antibody 
responses to protein antigens, immunoglobulin isotype class switch, somatic hypermutation and 
B cell memory (Davies and Thrasher 2010; Kawabe et al. 1994; Korthauer et al. 1993). Because 
primary responses to protein antigens proceed to establish memory, the specific requirements for 
the generation and/or maintenance of B cell memory cannot be exploited in their absence.  We 
have recently found that individuals with severe contraction of the T cell repertoire owing to 
removal of the thymus and depletion of mature T cells before cardiac transplantation in infancy 
do not develop hyper immunoglobulin M (IgM) syndrome and/or hypo-gamma-globulinemia, 
indicating some level of T cell help.  Preliminary studies in subjects of cardiac transplantation in 
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infancy suggested defective B cell memory to vaccination with protein antigens in spite of 
normal primary antibody responses.  These observations suggested that the T cell help required 
to generate primary antibody responses might differ in some respects from T cell help necessary 
to establish and/or evoke B cell memory responses (Ogle, West, Driscoll, Strome, Razonable, 
Paya, Cascalho and Platt 2006). Here we report that selection of affinity mature antibodies 
generated in response to protein antigens requires the integrity of the thymus.  
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MATERIALS AND METHODS 
Specific Aim 1, 2 and 3 
Strains of mice  
C57BL/6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). B cell-
deficient
 




by gene-targeted deletion of the JH 
segments (Chen, Trounstine, Alt, Young, Kurahara, Loring and Huszar 1993), and 
QuasiMonoclonal
 
(QM) mice, generated by gene-targeted replacement of the endogenous
 
JH 
elements with a VDJ rearranged region from a 4-hydroxy-3-nitrophenylacetate-specific
 
hybridoma (Cascalho, Ma, Lee, Masat and Wabl 1996). The JH
–/–
 mice lack mature B cells
 
and 
Ig (Chen, Trounstine, Alt, Young, Kurahara, Loring and Huszar 1993). QM mice have 80 % of B 
cells that are 4-hydroxy-3-nitrophenylacetate
 
specific (Cascalho, Ma, Lee, Masat and Wabl 
1996). Monoclonal B cell-T cell mice have monoclonal
 
B and T cell compartments; the T cells 
express a DO 11.10
 
transgenic cell receptor restricted to MHC class II
B
 (Keshavarzi, Rietz, 
Simoes, Shih, Platt, Wong, Wabl and Cascalho 2003).  
JH
–/– 
and QM mice were bred and all mice were housed in a specific
 
pathogen-free facility at the 
Mayo Clinic. All mice were between
 
6 and 18 wk of age, and all experiments were conducted in 
accordance
 
with protocols approved by the Mayo Clinic Institutional Animal
 
Care and Use 
Committee.
  
Determination of TCR V  diversity  
Isolation of RNA. Spleens harvested from mice were placed in RPMI 1640 and pushed
 
through 
a 70-µm cell strainer. Leukocytes were isolated
 
by Ficoll-Paque (Amersham Biosciences) 
gradient. Total RNA was
 





Generation of diversity standards. Diversity standards were prepared by generating 
oligonucleotide
 
mixtures of known diversity, as previously described (Ogle et al. 2003). For
 




, 18-mer oligonucleotides 
were synthesized with 10 sites
 
of random assignment generating 4
10










Oligonucleotides were biotin-labeled and hybridized
 
to the gene chips as explained below.
 
 
Generation of lymphocyte receptor-specific cRNA. First strand cDNA was obtained by 
reverse transcription with
 




Second strand synthesis and preparation of biotin-labeled cRNA
 
was conducted 
according to Affymetrix standard protocols.
 
 
Application of cRNA to the gene chip. Equal amounts of cRNA from different samples and 
diversity standards
 
were hybridized to U133B gene chips (Affymetrix). Gene chips
 
were 





Data analysis. Raw data corresponding to oligo location and hybridization intensity
 
were 
obtained. The number of oligo locations with intensity
 
above background (i.e., number of hits) 
was summed. A standard
 
curve was generated by hybridizing samples with known numbers
 
of 
different oligomers. Diversity of the test samples was estimated
 




CDR3 size spectratyping of TCR V   
PCR primers. Primers were synthesized by Mayo Molecular Biology Core Facility (Pannetier et 
al. 1995).
 
Two C  primers were designed to be homologous to the 3' end of
 
the constant region 
of the -TCR for the initial RT-PCR and a
 
second nested constant region primer near the 5' end 
of the
 
constant region was end labeled with Well RED D4 fluorescent
 
dye for detection on a 
CEQ 8000 DNA fragment analyzer (Beckman
 
Coulter). Twenty-four V  specific primers were 
synthesized to
 
distinguish individual V  genes (Rodriguez et al. 1993).
 
 
cDNA production. cDNA was produced using a C  constant region primer in a RT-PCR
 
amplification. The reverse transcriptase reaction was performed
 
using Moloney murine leukemia 
virus reverse transcriptase (Invitrogen
 
Life Technologies) by incubating heat-denatured RNA 
template
 
and the constant region primer (Nest I) at 37°C for 40 min
 
and 42°C for 20 min 
followed by a heat-deactivating incubation
 





10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.25 mM MgCl2, and 0.25
 
mM dNTP in a 
final volume of 5 µl per reaction.
 
 
cDNA amplification. Following cDNA synthesis, provision for a subsequent "hot-start"
 
PCR 
was made by adding an AmpliWax PCR Gem 100 tablet (PerkinElmer)
 
to each tube before 
incubation in the cycler at 100° for
 
5 min. This incubation inactivates the Moloney murine 
leukemia
 
virus reverse transcriptase and melts the wax tablet. After
 
removing the tubes from the 
cycler, the wax layer was allowed
 
to set for 1 min and an upper PCR mix was added. This layer
 
consisted of 5 mM MgCl2, 10 mM Tris-HCl (pH 8.3), 50 mM KCl,
 
5 pmol of a specific V  
variable region primer, and 0.5 U of
 
Taq polymerase (Promega) in a final volume of 20 µl. PCR
 
cycling parameters were one cycle of denaturation at 94°
 
for 5 min, annealing at 56° for 30 s, and 
extension at 72°
 
for 1 min followed by 29 cycles with denaturation at 94°
 
for 40 s and the same 
annealing and extension parameters. A
 
final extension was conducted at 7° for 5 min.
 
 
Second nested PCR for labeling. A second nested PCR was performed to label the products 
from
 
the first amplification reaction. One microliter of the first
 
PCR was used as template for the 
second reaction. The same specific
 
V  variable region primers were used and a nested constant 
region
 
primer (GAGGGTAGCCTTTTGTTTGT) with a fluorescent tag, WellRED
 
D4 (Proligo), 
for detection on a Beckman CEQ 8000 DNA fragment
 
analyzer for all reaction products. This 
reaction consisted
 
of 5 mM MgCl2, 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 5 pmol of
 
a specific 
V  variable region primer, and 0.6 U of Taq polymerase
 
in a final volume of 25 µl. PCR cycling 
parameters were
 
one cycle of denaturation at 94° for 2 min, annealing at
 
56° for 30 s, and 
extension at 72° for 1 min followed
 
by 29 cycles with denaturation at 94° for 40 s and the same
 
annealing and extension parameters. A final extension was conducted
 
at 72° for 5 min. Data 
acquisition and peak detection were
 
handled by the manufacturer’s supplied software for the
 
CEQ 8000 (Beckman Coulter).
 
 





 mice with an RNeasy mini kit (Qiagen). cDNA
 
was obtained by reverse transcription with a 
ThermoScript RT-PCR
 
system (Invitrogen Life Technologies). Amplification of V  sequences
 
were done using 10 pmol of the V  8.1 specific (forward) primer
 




(GAGACCTTGGGTGGAGTCAC), and 1.25 U of PfuTurbo DNA polymerase
 
(Stratagene) in 
50 µl. PCR conditions were 35 cycles of
 
94°C for 30 s, 60°C for 30 s, and 72°C for 1 min
 
followed by a final extension at 72°C for 7 min. The presence
 
of a PCR product was detected by 
visualizing the appropriate
 
size bands on 1.5 % agarose following gel electrophoresis. The
 
PCR 
products were cloned using TOPO TA cloning (Invitrogen Life
 
Technologies). Sequencing was 
performed at the Mayo Clinic Molecular
 
Biology Core Facility using an M13 (forward and 
reverse) primer.
 
Analysis of the sequences was done with Sequencher software
 
(Gene Codes 
Inc.), and the sequences were aligned using the
 
software provided by the international 
information system of
 
ImMunoGeneTics, IMGT (M.-P. Lefranc, Montpellier, France; 
http://imgt.cines.fr)
 
(Bosc and Lefranc 2000; Giudicelli et al. 2005).
 
The following is a list of the 
specific V  variable primers used
 
and their sequences (5' to 3') with the IMGT nomenclature 
according
 
to Bosc and Lefranc (Bosc and Lefranc 2000) in parentheses:  
V 1 (IMGT V 5), CTGAATGCCCAGACAGCTCCAAGC; 
 
V 2 (IMGT V 1), CAAAGAGGTCAAATCTCTTCCCGGTG; 
 V 3 (IMGT V 26), GTTCTTCAGCAAATAGACATCACTG; 
 
V 4 (IMGT V 2), CTTATGGACAATCAGACTGCCTCA; 
 V 5.1 (IMGT V 12-2), CATTATGATAAAATGGAGAGAGAT; 
 
V 5.2 (IMGT V 12-1), AAGGTGGAGAGAGACAAAGGATTC; 
 V 5.3 (IMGT V 12-3),
 
AGAAAGGAAACCTGCCTGGTT; 
 V 6 (IMGT V 19), TCAATAACTGAAAACGATCTT; 
 
V 7 (IMGT V 29), TACGATGTTGATAGTACCAGCG; 
 V 8.1 (IMGT V 13-3), CATTACTCATATGTCGCTGAC; 
 
V 8.2 (IMGT V 13-2), CATTATTCATATGGTGCTGGC; 
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 V 8.3 (IMGT V 13-1),
 
TGCTGGCAACCTTCGAATAGGA; 
 V 9 (IMGT V 17), ATGATAAGATTTTGAACAGGGA; 
 
V 10 (IMGT V 4), GCAATCCATTGTAAACGAAACAG; 
 V 11 (IMGT V 16), CAAGCTCCTATAGATGATTCAGGG; 
 
V 12 (IMGT V 15), AAGTCTCTTATGGAAGATGGTGG; 
 V 13 (IMGT V 14), TCCTCTATAACAGTTGCCCTCG; 
 
V 14 (IMGT V 31), TGTTGGCCAGGTAGAGTCGGTGCAA; 
 V 15 (IMGT V 20), GCACTTTCTACTGTGAACTCAGC; 
 
V 16 (IMGT V 3), GGTAAAGTCATGGAGAAGTCTAAAC; 
 V 17 (IMGT V 1), AGAGATTCTCAGCTAAGTGTTCCTCG; 
 
V 18 (IMGT V 30), CAGCCGGCCAAACCTAACATTCTC; 
 V 19 (IMGT V 121), CTGCTAAGAAACCATGTACCA; 
 
V 20 (IMGT V 23), TCTGCAGCCTGGGAATCAGAA.
 
 
Fluorescence activated cell sorting analysis  
Splenocytes were obtained by pushing minced spleen tissue through
 
a 0.70-µm mesh followed by 
hemolysis in an NH4Cl lysis
 
buffer. The total number of splenocytes was determined using
 
a 
Neubauer chamber. Cells were stained with one, two or three
 
of the following mAbs (all the Abs 
were from BD Pharmingen)
 
as described (Cascalho, Ma, Lee, Masat and Wabl 1996): FITC-
conjugated rat anti-mouse CD4 (clone
 
GK1.5), rat anti-mouse CD8  (clone Ly-2), and rat anti-
mouse
 
CD19 (clone 1D3); PE-conjugated rat anti-mouse CD8  (clone 53-6.7)
 
and rat anti-mouse 
CD44 (Pgp-1, Ly-24); and biotin-conjugated
 
rat anti-mouse CD62L (LECAM-1, Ly22) and rat 
anti-mouse CD3
 





16S) was bought from eBioscience. Lymphocytes were gated
 









cells; numbers of the splenocytes in the subpopulations 
were
 
determined by multiplying their total number by the percentage
 
as defined by gating on the 
FACS plot. Data were collected on
 






T cell priming to Pan DR reactive epitope (PADRE) peptide  
Age-matched B6 mice were injected subcutaneously with the 140-µg
 
PADRE peptide 
aK(X)VAAWTLKAAa, where "a" is alanine and X is
 
cyclohexyl alanine (Wei et al. 2001) in 




were purified from draining lymph node and spleens and 
cultured
 
with dendritic cells isolated according to Kodaira et al. (Kodaira et al. 2000)
 
and 
matured by incubation with LPS (from Escherichia coli 0111:B4;
 
Sigma-Aldrich) at 5 µg/ml 
overnight in the presence of
 
PADRE (35 µg/ml) for 5 days. Data represent the mean counts
 
per 





Delayed-type hypersensitivity assay  
Mice were primed by the injection of 100 µg of OVA subcutaneously
 
and challenged by 
intradermal injection of 20 µg of OVA
 
in the footpad 6 days after priming. Non primed mice 
controls
 
were included. Effective swelling was indicated by the difference
 
in thickness measured 
with a caliper between Ag-injected footpad
 
and a PBS-injected footpad. Responses were 





T cell proliferation assay  
Isolated CD4
+




ware cultured in a 96-well plate 
coated with anti-CD3 (clone
 
H57-597) (in three different concentrations: 0.2, 1, and 10
 
µg/ml) in 
the presence of anti-CD28 at 10 µg/ml
 
for 48 h. Alternatively, T cells were cultured with Con A 
(BD
 
Biosciences) (in three different concentrations (ConA to medium):
 
1/20, 1/10, and 1/5) in 
the presence of anti-CD28 at 10 µg/ml
 





Data represent the mean counts per minute of three wells ±
 






Skin grafts  
Skin grafts were performed according to a modified technique
 
of Billingham et al. (Billingham et 
al. 1953). Briefly, full thickness tail skin
 
(0.5 x 0.5 cm) was grafted onto the lateral flank. Grafts 
were
 
observed daily after removal of the bandage at day 8. Grafts
 
were considered rejected when 
90 % or more of the graft lacked
 
any viable signs (hair, pigment, and scale pattern). All mice
 
were grafted between 6 and 18 wk after birth. Re-transplants
 
were performed 16–20 wk after the 
primary graft was shed.
 
 
Pneumocystis murina infection and assessment of organismal burden  
P. murina was isolated from the lungs of heavily infected, SCID
 
mice as previously described 
(Keely et al. 2004). The infected lungs were aseptically
 
minced and disaggregated in a 
Stomacher laboratory blender.
 
Pneumocystis organisms were isolated by differential 
centrifugation,
 
washing, and filtration through micropore filters containing
 
10-µm pores as 
previously reported (O'Riordan et al. 1995). The organisms
 
were resuspended in freezing 
medium (RPMI 1640 with glutamine
 
containing 10 % FCS and 7.5 % DMSO), aliquoted, and 
frozen in
 





As described by Shellito et al. (Shellito et al. 1990), inoculation was performed
 
by inserting a 22-
gauge feeding tube into the trachea of anesthetized
 
animal, visualizing its position through the 5-
mm long incision
 





organisms) followed by 300 µl of air.
 
Control animals were injected with 75 µl of saline 
followed
 
by 300 µl of air. Two weeks after the infection the mice
 
were sacrificed and the lungs 
were removed and frozen until
 





Quantitative RT-PCR to enumerate Pneumocystis was performed
 
using the Bio-Rad iCycler 
System, SYBR Green detection software,
 
and primers targeting the Pneumocystis large 
mitochondrial subunit
 
(Wakefield et al. 1990). Lung DNA was isolated by phenol-chloroform 
extraction
 
and ethanol precipitation and finally resuspended in Tris-EDTA
 
buffer. Amplifications 
of unknown samples were compared with
 
plasmid standards containing mouse Pneumocystis-
specific mitochondrial
 





Statistical analysis  
Statistical analysis for comparison of the TCR V  diversity of
 
groups was performed using 
natural log transformation of the
 
data and subsequent one-way ANOVA. The comparison of the 
groups
 
was performed by an unpaired, two-sided Student’s t test
 
on the natural log transformed 
data. Group comparisons of the
 
numbers of T cells in the splenocyte subpopulations were 
performed
 
using the Student’s t test after testing the global difference
 
with a one-way ANOVA. 
Comparison of skin graft survivals was
 




















Specific Aim 4 and 5 
 
Strains of mice 
C57BL/6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). Mice 
were housed in a specific pathogen-free facility at the University of Michigan.  All mice were 
between 5 and 25 weeks of age and all experiments were carried out in accordance with 
protocols approved by UCUCA. 
Thymectomy and gene analysis 
Thymectomy: Thymuses were removed surgically from mice or sham-surgery was performed at 
5 weeks of age.  Mice were anesthetized with ketamine (120-200 mg/kg) + xylazine (10 mg/kg) 
i.p.  An incision was made on the ventral neck midline extending from 0.5 cm cranial of the 
sternal notch.  The clavicle was cut along the sternum to the second rib and retracted to expose 
the trachea, sternohyoid and sternothyroid muscles which were gently separated to expose the 
superior end of the thymic lobes.  The thymus was then gently dissected with blunt instruments 
and excised by vacuum.  The thorax was closed using 6-0 absorbable suture placed through the 
dorsal thorax to draw the clavicle and ribs together.  The fat pad with the submaxillary gland was 
returned to its original position and held in place by liquid skin adhesive.  Skin was closed using 
6-0 absorbable suture.  Mice were monitored every 12h for the first 48h, and daily thereafter.  
Sham-operated mice underwent the same surgical procedure, except for the fact that the thymus 
was not excised, just manipulated with the tip of blunt scissors. 
Blood collection: Done following the recommendations of the University of Michigan 
Committee on Use and Care of Animals (UCUCA).  
Immunizations: T-independent immunizations were performed as explained by Mantchev et al. 
(Mantchev et al. 2007) by injecting mice i.p. with 30 µg of NP-Ficoll (NP41- AECM-Ficoll; 
Biosearch Technologies, Novato, CA, USA) diluted in 100 µl PBS once.  Primary T-dependent 
immunizations were performed by i.p. injection of 100 μl of an emulsion of incomplete Freund’s 
adjuvant containing 100 µg NP (25)-ovalbumin (Biosearch Technologies, Novato, CA, USA) 
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and boost immunizations performed by i.p. injection of 100 μl of a PBS solution containing 10 
µg NP (25)-ovalbumin.  To obtain RNA from memory B cells, mice were boosted a second time 
by i.v. injection of 50 µg NP (25)-ovalbumin dissolved in 100 μl of PBS.  
Ig gene analysis: RNA was obtained from spleen cells and extracted with QIAGEN RNeasy 
(Qiagen, Inc., Valencia, CA, USA).  cDNA was obtained from 0.2 µg of RNA using oligo(dT) 
primed reverse transcription.  VH186.2 gene sequences joined to the IgG1 constant region were 
amplified with VH186.2 and C1 specific primers in a nested reaction and with Pfu polymerase, 
followed by cloning with pCR4-TOPO (Invitrogen, USA).  Sequencing of cloned PCR fragments 
was done by the Mayo Clinic Sequencing Core. Forward primer: 
CATGCTCTTCTTGGCAGCAACAGC (specific for VH186.2), reverse primer: 
GTGCACACCGCTGGACAGGGATCC (specific for C 1).  PCR was performed for 30 cycles 
of 1 minute at 94
0
 Celsius, 2 minutes at 55
0
 Celsius, and 3 minutes at 72
0
 Celsius.  Nested PCR 
amplification forward primer: CAGGTCCAACTGCAGCAG, and reverse primer, 
AGTTTGGGCAGCAGA.  Sequences were aligned and analyzed using Sequencher software 
(Gene Codes, MI, USA) and with a software program developed by Dr. Calvacoli at the 
University of Michigan Sequencing Core.  VH, D and JH gene CDR3 sequence assignments 
were done according to the international ImMunoGeneTics (IMGT) system software developed 
by Dr Lefrank at the CNRS, France (Giudicelli, Chaume and Lefranc 2005).  Complementary 
determining regions were determined according to Kabat et al. (Kabat et al. 1991). 
FACS analysis and antibodies 
Splenocytes were obtained and prepared for flow cytometry analysis as in (Cascalho, Ma, Lee, 
Masat and Wabl 1996).  Fluorescently conjugated or biotinylated antibodies were purchased 
from BD Biosciences unless noted: rat anti-mouse CD4 (GK 1.5), rat anti-mouse CD21a/CD35 
(7G6), rat anti-mouse CD3 (145-2C11), rat anti-mouse IgD
b
 (AMS9.1), rat anti-mouse CD4 
(GK1.5), rat anti-mouse CD44 (Pgp-1, Ly-24), rat anti-mouse CD23 (Fc ε RII), rat anti-mouse 
IgMb (DS-1), rat anti-mouse CD8 (Ly-2), rat anti-mouse CD19 (1D3), rat anti-mouse CD62L 
(LECAM-1, Ly22), rat anti-mouse CD25 (IL-2R α chain, p55) and rat anti mouse Foxp3 (FJK-
16S, eBiosciences).  Biotinylated antibodies (Abs) were revealed by streptavidin-PE-Cy5 
purchased from BD Biosciences, USA.  Data were collected on a FACScalibur (BD Biosciences) 
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and analyzed with CellQuest software (BD Biosciences).  Isotype controls were used to define 
gates.   
Delayed type hypersensitivity (DTH) assay  
Mice were primed by subcutaneous injection of 100 µg of ovalbumin dissolved in PBS, and 
challenged by intra-dermal injection of 20 µg of ovalbumin in PBS in the footpad, 6 days after 
priming.  Non-primed mice challenged with PBS were included as controls.  Footpad swelling 
was measured with a caliper.  Effective swelling indicates the difference in the thickness of 
footpads in the same mice (one injected with the antigen, another injected with PBS).  Responses 
were recorded at 24 and 48 hours post-challenge. 
Skin Grafts 
Skin grafts were performed according to a modified technique of Billingham et al. (Billingham, 
Brent and Medawar 1953).  Secondary transplants were 30 days after the primary graft was shed.  
TRECS (T cell receptor excision circles)  
DNA was obtained from splenocytes with a DNeasy Blood and Tissue Kit (Qiagen, Inc., 
Valencia, CA, USA).  PCR amplification of sjTREC DNA was done from 100 ng of DNA in a 
Mastercycler ep realplex real-time PCR system (Eppendorf) using specific primers targeting 
murine δRec-ψJα excision circles.  Real-time PCR cycler conditions were set for 95
0
C for 10’ 
followed by 40 cycles of 95
0
C for 15’’ and 60
0
C for 1’ with 5µM forward and reverse primers 
and 0.05µl of 100µM FAM-QSY probe.  Forward primer (upstream of ψJα segment): 5’CAT 
TGC CTT TGA ACC AAG CTG3’; Reverse primer (downstream of the δRec1 segment): 5’TTA 
TGC ACA GGG TGC AGG TG3’ according to (Sempowski and Rhein 2004).  A fluorescent 
probe for RT-PCR: FAM - CAG GGC AGG TTT TTG TAA AGG TGC TCA CTT - QSY 
(Applied Biosystems).  The mouse transferring receptor gene Tfrc gene (TaqMan Copy Number 
Reference Assay, Applied Biosystems) was amplified to quantify cell number in mouse DNA 
samples.  Each sample was run in triplicate.  Standard curves were created with either serial 
dilutions sjTREC plasmid DNA or of C57BL/6J DNA followed by Tfrc gene amplification.  
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ELISA (Enzyme-linked immunosorbent assay)   
MaxiSorp-treated or PolySorp-treated polystyrene 96-well plates (Thermo Scientific, Rochester, 
NY, USA) were coated with 4 μg/mL of goat anti-mouse Ig (SouthernBiotech, Birmingham, AL, 
USA) in PBS to measure total Ig, or with 5 μg/mL of NP-BSA in borate saline buffer to detect 
NP-specific antibodies, for 1 hour at room temperature.  ELISA was performed according to 
previously described protocols (Cascalho, Ma, Lee, Masat and Wabl 1996; Cascalho et al. 1997).  
Plates were developed with ABST (SouthernBiotech, Birmingham, AL, USA) read at 405 nm in 
microplate reader Synergy 2 (BioTec Laboratories Ltd., Suffolk, UK) and analyzed using Gen 5 
software version 1.04.5 (BioTek, VT, USA).  The 17.2.25 IgGl was used as a standard for 
quantification.  
ELISPOT (Enzyme-linked immunosorbent spot)   
Done according to standard procedures in the laboratory (Mantchev, Cortesao, Rebrovich, 
Cascalho and Bram 2007).  MultiScreen HTS-HA 96-well plates (Millipore, Billerica, MA, 
USA) were coated with 5 μg/mL NP-BSA or 5 μg/mL BSA in sodium carbonate buffer 
overnight at 4°C and blocked with 5 % milk in TBS-Tween for 2 hours at 37°C.  B cells isolated 
from the spleen by negative selection were serially diluted, seeded in the wells and cultured in 
complete RPMI-1640, overnight at 37°C in 5 % CO2 atmosphere.  ELISPOT analyses of 
antibody secreting cells obtained from adoptively transferred recipients were done with 
splenocytes.  To detect NP-specific antibody secreting cells, each well was washed and 
incubated with AP-conjugated goat anti-mouse IgM or IgG antibody (SouthernBiotech, 
Birmingham, AL, USA) for 2 hours at 37°C.  Each well was developed with BCIP/NBT (Sigma-
Aldrich, St. Louis, MO, USA).  The number of spots of NP-specific IgM or IgG secreting cells 
was counted by ImmunoSpot Professional Analyzer version 5.0.9 (Cellular Technology Ltd., 
Shaker Heights, OH, USA) and confirmed by direct observation.  
TCR beta chain diversity analysis 
TCR beta chain diversity analysis was done as reported (Wettstein et al. 2008).  Briefly, RNA 
was obtained from spleens using a RNeasy Protect Minikit (Qiagen, CA).  Residual DNA was 
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removed from RNA samples using a RNase-Free DNase Set (Qiagen).  cDNA was produced 
from 15 ng of RNA with a 20 pmol of a 5’biotynilated TCR Cb primer and pools of 21 
different TCR V primers homologous to the CDR 1 region providing 66 pmol of each (three 
pools of 5 and one pool of 6 primers), at 50
0
C for 32’ followed by incubation at 94
0
C to 





C, and 1’ at 72
0
C for  25 cycles.  RT-PCR products were purified by QIAquick 
PCR Purification Kit (Qiagen) and biotynilated products separated with MyOne
TM
 Streptavidin 
C1 Dynabeads (Dynal Biotech ASA, Oslo, Norway) according to the manufacturers’ 
instructions.  TCR V diversity was determined by real time PCR in a total of 240 individual 
reactions using combinations of 20 TCR V and 20 TCR J primers, as described (Wettstein, 
Strausbauch, Therneau and Borson 2008).  Reactions were performed in a 10 ml volume 
containing 10 pmol of a nested TCR V primer homologous to TCR V CDR2, 10 pmol of a 
TCR J primer, l µl of purified PCR products and 5 l of Power SYBR Green PCR master mix 
(2x) (Applied Biosystems).  Cycling was preceded by incubation at 50
0
C for 2’ and at 95
0
C for 
10’, followed by 40 cycles of 15’’ at 95
0
C and 1’ at 60
0
C.  Data were analyzed with the 7900HT 
Sequence Detection System Version 2.3 software (Applied Biosystems) to estimate the cycle 
threshold (Ct) for all reactions.  Ct values are fractional cycle numbers at which fluorescence 
passes the threshold set to be within the exponential region of the amplification curve 
corresponding to a linear relationship between the log of change in fluorescence and cycle 
number.  Primers were as published (Wettstein, Strausbauch, Therneau and Borson 2008) and 
synthesized by Invitrogen (Carlsbad, CA, USA).  
Statistical analysis 
Performed using Prism software (Prism Software Corporation, Irvine, CA).  Group comparisons 
were performed using the unpaired, two-sided Student’s t test after testing the global difference 
with a one-way analysis of variance (ANOVA).  Comparison of skin graft survival was 






Specific Aim 1, 2 and 3 
Diverse B cells and Ig maintain T cell numbers in the spleen and TCR 
diversity  
Competence of the T cell compartment, particularly cell-mediated
 
immunity, is thought to 
depend upon the number and diversity
 
of T cells available to respond to antigenic challenge 
(Nikolich-Zugich, Slifka and Messaoudi 2004).
 
T cell diversity would seem to assure that one or 
more clones
 
of T cells will bear a TCR capable of recognizing a peptide(s)
 
from a 
microorganism, a toxin, or a minor histocompatibility
 
Ag associated with self-MHCs, thus 
allowing the activation of
 
rare Ag-specific T cells (Kanagawa et al. 1982; Lindahl and Wilson 
1977; Suchin et al. 2001). To test this concept,
 
we studied the structure of the T cell compartment 
and cell-mediated
 
immunity in mice with defects in Ig assembly.
 
 
We asked whether mice with B cell defects have normal numbers
 







 T cells in the
 
spleen of QM mice were not significantly changed compared 
with
 
those of wild-type mice (p > 0.05), indicating that QM mice
 
with oligoclonal B cells 
maintain normal numbers of T cells
 







 but not CD8
+
 T cells were significantly decreased in JH
–/– 
mice (p < 0.05). This finding 
is in agreement with the observations
 
of Ngo et al. (Ngo et al. 2001), who showed reduced T cell 
numbers in the
 
spleen of B cell deficient µMT mice.
 
 
We next tested whether mice with B cell defects and low diversity of thymocytes (Joao, Ogle, 
Gay-Rabinstein, Platt and Cascalho 2004) also have decreased diversity in the periphery. TCR 
V  diversity was measured according to Ogle et al. (Ogle, Cascalho, Joao, Taylor, West and 
Platt 2003). In this assay, T cell diversity is proportional to the number of hybridization hits of 
TCR V  cRNA on a gene chip and quantified by comparison to a standard curve obtained with 
DNA oligomers of known diversity. TCR V  diversity of JH–/– splenocytes was 1.1 x 103 per 
10 µg of RNA, whereas TCR V  diversity of C57BL/6 splenocytes was 1.3 x 106 per 10 µg of 
RNA (p < 0.05). TCR V  diversity of QM splenocytes was intermediate, 8.8 x 104 per 10 µg of 
RNA (p < 0.05, compared with C57BL/6). In addition to the specificity of the primers, we 
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assured that the assay detected TCR V  diversity and not B cell diversity, because sorted 1.5 x 
107 B cells from C57BL/6 splenocytes containing 0.09 % of CD3+ cells yielded a mean 
diversity of only 136 corresponding to 0.023 % of the diversity obtained from equal number of 
splenocytes containing 20 % of CD3 positive cells. Because QM mice are B cell and Ig 
proficient, our results indicate that T cell diversity in the spleen is not a function of B cell 
number and/or of serum Ig concentration (Joao, Ogle, Gay-Rabinstein, Platt and Cascalho 2004) 
but may rather depend on the diversity of Ig in the serum and/or on the surface of B cells.  
T cell function in mice with contracted TCR diversity  
We next tested whether T cells from mice with a contracted T cell repertoire exhibit normal 
functions at a cellular level. As Figure. 2 shows, T cells from JH–/– and QM mice proliferated in 
response to anti-CD3 (Figure. 2A) or Con A (Figure. 2B), as did T cells from C57BL/6 mice. 
Next, we asked whether T cells in JH–/– and QM mice could be primed in vivo. To this end, 
mice were injected with 140 µg of the PADRE peptide and 14 days later CD4+ T cells purified 
from the spleen were cocultured with mature dendritic cells in the presence of 35 µg/ml PADRE 
peptide. Figure. 3 shows that QM T cells mount robust proliferation and JH–/– T cells have 
detectable albeit reduced proliferation (26 % of QM or 27 % of C57BL/6 values) to the PADRE 
peptide. The results indicate that 90 % contraction of the TCR repertoire (in QM mice) does not 
impair priming of T cells and that 99 % contraction, as in JH–/– mice, does not preclude T cell 
priming.  
Lymphoid organogenesis in mice with contracted TCR repertoires  
Aberrant T cell response in JH–/– mice could be due to the contraction of TCR diversity or to 
defective lymphoid organogenesis. We questioned whether T cells from JH–/– mice respond 
normally to mitogens but fail to undergo priming because of defective lymphoid organogenesis. 
Golovkina et al. (Golovkina et al. 1999) showed that lack of B cells in JH–/– mice causes 
defective peripheral lymphoid organogenesis with an absence of Peyer patches and a follicular 
dendritic cell network. Consistent with this possibility, Figure. 4 shows that although JH–/– 
lymph nodes lack a follicular dendritic cell network, QM mice have a normal one, suggesting 
37 
 
that abnormal lymph nodes rather than contracted T cell diversity in JH–/– mice could contribute 
to defective T cell priming.  
Impact of TCR diversity on cell-mediated immunity  
We next asked to which extent contraction of the T cell repertoire
 
per se impairs cell-mediated 
immunity. To avoid the confounding
 
influence of impaired lymphoid organogenesis, we 
addressed the
 
question using QM mice that show nearly normal lymph nodes.
 
First, we compared 
the rate of rejection of skin allografts
 
by QM and C57BL/6 mice. The outcome of skin grafts is 
thought
 
to be independent of Ab responses directed against the graft (Bogman et al. 1984; 
Cascalho and Platt 2001; Parker et al. 1996) and, hence, this test could be conducted in mice
 
with 
oligoclonal B cells. The kinetics of rejection of allografts
 
is modified in animals with defective 
lymphoid organogenesis (Lakkis et al. 2000) or T cell signaling (Harmsen and Stankiewicz 1990; 
Ito et al. 2005) and, therefore, the assay would
 
help exclude these problems. Table 1 shows that 
MHC-disparate
 
skin grafts were rejected with similar kinetics by QM and wild-type
 
recipients. 
This result suggests that the QM mice have functional
 
lymph nodes and that their T cells have the 
capacity to function
 
like T cells from wild-type mice.
 
 
We next tested the outcome of grafts across a minor histocompatibility
 
barrier. We reasoned that 
contracted TCR diversity would more
 
likely hinder responses to minor than to major 
histocompatibility
 
Ags, because the frequency of T cells specific for those Ags
 
is less by orders 
of magnitude than the frequency of T cells
 
specific for allogeneic MHC (Kanagawa, Louis and 
Cerottini 1982; Lindahl and Wilson 1977; Suchin, Langmuir, Palmer, Sayegh, Wells and Turka 
2001). For this test, skin
 
from the tails of male mice was transplanted onto female mice
 
flanks. 




male skin grafts as reliably as wild-type mice 
and with the
 
same kinetics at 26 or 23 days (median), respectively, while
 
C57BL/6 females 
rejected male skin grafts at 23 days (median)
 
(Table 1 and Figure. 5). QM and wild-type mice 
rejected secondary
 
skin grafts always faster than primary grafts (Table 2). These
 
results indicate 
that contraction of the repertoire of T cells
 






To confirm that contraction of the TCR repertoire has little
 
impact on cell-mediated immunity, 
we tested the responses to
 
OVA in QM, JH
–/–
, and C57BL/6 mice. Responses to
 
OVA were 
examined in mice primed 6 days earlier by measuring
 
the footpad thickness at 24, 36, and 60 h 
following intradermic
 
injection of 20 µg of OVA. Mice were either primed by
 
s.c. injection with 
100 µg of OVA or injected with PBS
 
(not primed controls). Footpad swelling did not differ 
between
 
QM and wild type mice (Figure. 6) at 60 h following challenge.
 
However, footpad 
swelling was decreased in QM mice at 36 h after
 
challenge, suggesting a delayed kinetics 
compared with that
 
of C57BL/6 mice. JH
–/–
 mice had decreased footpad
 
swelling 36 and 60 h 
after challenge, which could be due to
 
defective lymphoid organogenesis (see above). The 
footpad swelling
 
reflected cell-mediated immunity because it was fully prevented
 
by daily 
injection with cyclosporin A (600 µg/day i.p.
 
for 3 days) (data not shown). 
Impact of TCR repertoire contraction in host defense  
As a further test of cell-mediated immunity, we asked whether
 
host defense was challenged by 
TCR repertoire contractions.
 
To test the impact of contracted TCR repertoire on host defense,
 
we 
infected QM or C57BL/6 mice with P. murina and measured the
 
organism burden in the lungs 2 
wk later. Pneumocystis is an
 
intracellular pathogen, the elimination of which depends on
 
T cells; 
T cell-deficient mice fail to clear the agent, ultimately
 
causing pneumonia and the death of the 
host (Harmsen and Stankiewicz 1990). Figure. 7 shows
 
that the level of Pneumocystis in the 
lungs of QM or C57BL/6
 
mice 2 wk postinfection was similar. Thus, contraction of the
 
TCR 
repertoire did not compromise host defense. 
TCR repertoire contraction in B cell-deficient mice is balanced  
Those with impaired cell-mediated immunity caused by AIDS or
 
DiGeorge syndrome have both 
TCR diversity contractions and gaps
 
and/or oligoclonal expansions (Giacoia-Gripp et al. 2005). 
Whether these changes impair
 
immunity is unknown. To address that question, we evaluated
 
the 
TCR V  repertoire in mice with severely contracted diversity
 
by spectratyping and sequencing.
 
 
TCR -chain CDR3 lengths for each V  gene spectratype were generated
 
for each of the V  




 and three C57BL/6 mice 
according
 





of the 24 V  genes were associated with spectratypes exhibiting
 
Gaussian distributions. 
There were a limited number of exceptions
 
as described in Figure. 8, where single peaks were 
over-represented
 
against a background of normally distributed CDR3 lengths. Thus,
 
the 
contracted repertoire in JH
–/–
 mice did not
 
alter the distribution of CDR3 lengths, indicating that 
contraction
 
was balanced in contrast to what is observed in immunodeficiencies
 
such as AIDS 
(Connors et al. 1997; Gorochov et al. 1998).
 
 
To determine whether a normal spectratype profile reflects a
 
balanced contraction of the 
repertoire, we sequenced the TCR
 
CDR3 regions of genes containing V 13-3 (IGMT designation 
for
 
V 8.1) in splenocytes obtained from C57BL/6 (Table 3), QM (Table 4), or JH
–/–
 mice (Table 





those of wild-type mice. Of 46 C57BL/6 sequences
 
bearing V 13-3, 29 had different CDR3 
regions, the lengths of
 
which averaged 11.5 codons. Of 45 QM sequences bearing V 13-3,
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had different CDR3 regions, the lengths of which averaged
 





54 had different CDR3 regions, the lengths of which averaged
 
11.9 codons. The 
CDR3 lengths of sequences containing the TCR
 
V 13-3 obtained from mice of all strains 
showed a Gaussian distribution,
 
as one might expect if differences in repertoire diversity were
 
balanced. In further support of an equilibrated contraction
 
without oligoclonal expansions, Table 
4 shows that the V  sequences
 
obtained from all of the mice used diverse J  segments. These
 
results demonstrated that B cell-deficient mice have balanced
 
contraction of TCR diversity and 
suggest that it is the gaps
 
and oligoclonal expansions and not the repertoire contraction
 
in itself 







 and regulatory T cells in mice with contracted TCR repertoire 
 
The normal kinetics of skin graft rejection in mice with profound
 
contraction of the TCR 
repertoire suggested that the T cell
 
compartment had "compensated" in some way. We 
hypothesized that
 
such compensation might occur if T cells had proliferated to
 
maintain the 
dimensions of the T cell compartment and, as a
 
result, acquired "memory-like" functions 
(Mackall et al. 1997; Tanchot et al. 1997). To explore
 
this possibility, we enumerated "memory-




, or C57BL/6 mice based on phenotype (Berard and 
Tough 2002; Berg et al. 1991; Goldrath et al. 2000; Sallusto et al. 1999). Figure. 9 shows that 
QM mice had 3-fold and JH
–/– 
2-fold more "memory-like" CD4
+















 T cells. These results suggest that the T cell compartment
 
compensates for the contraction 




Because thymic dysfunction or thymectomy 
performed in the second
 
to the third day of life impairs the production of natural T
 
regulatory T 
cells (Kim and Rudensky 2006), we questioned whether B cell-deficient
 
mice might have 
impaired production of T regulatory cells, thus
 
enhancing cell-mediated immunity. To address 
this question,
 
we determined the number of T regulatory cells in QM and JH
–/– 
mice. The relative 
number of Forkhead box P3-positive T cells
 
(a marker of T regulatory cells) (Fontenot et al. 




 mice, 1.8 % in QM mice, and 1 % in wild-type
 
mice. Our 
results thus indicate that the maintenance of cell-mediated
 
immunity cannot be ascribed to loss of 
natural regulatory T
 
cells. Whether a 2-fold relative increase in T regulatory cells
 
may modify or 
control T cell responses in mice with contracted
 





















Specific Aim 4 and 5 
 
Removal of the thymus of mature mice causes a persistent decrease in the 
number of CD4+ or CD8+ T cells without contracting T cell receptor diversity 
To explore the role of the thymus in B cell memory responses we removed the thymus of mice at 
5 weeks of age reasoning that at this age mice already have an established T cell compartment 
and competent cellular immunity (Miller 1965). Removal of the thymus at 5 weeks of age 
completely abrogated recent thymic emigrants because mice lacking the thymus (in the 
manuscript referred to as athymic mice) lacked any measurable T cell receptor excision circles 
(TRECs) at 5 and 10 weeks following thymectomy (Figure 10). Consistent with absent thymic 
function, athymic mice had reduced CD4+, CD25+, Foxp3 cells, at 10 weeks of age ( Figure 11). 
Mice from which the thymus had been removed (athymic mice) at 5 weeks of age had fewer T 
cells in the spleen 5 and 10 weeks after the surgery, compared to control mice.  Figures 12A, 
12B and Table 6 show that thymectomy caused a persistent 2.8 or 3.0 fold decrease in the 
number of CD4+ or CD8+ T cells respectively, 10 weeks after surgery.  Sham operation of the 
thymus also decreased the number of CD4+ or CD8+ T cells 10 weeks after surgery, albeit less 
profoundly than removal of the thymus (Figures 12 A, 12 B and Table 6). Results from other 
laboratories are consistent with ours showing close to 2 fold reduction in the number of CD4 T 
cells in the spleen.  Thus, Gagnerault et al. (Gagnerault et al. 2009) found a 2 fold reduction in 
the number of CD4 T cells in the spleen following thymectomy in 3-week-old mice; and 
Bourgeois et al. (Bourgeois et al. 2008) found a reduction of almost 2 fold in the number of 
peripheral CD4-positive T cells 15 weeks after interrupting thymic output in a model of chemical 
thymectomy. 
To determine whether the removal of the thymus caused compensatory proliferation, we 
enumerated CD4+ or CD8+ cells with a memory-like phenotype (CD62L-negative and with high 
expression of CD44).  Figures 12C, 12D and Table 6 show that athymic mice and controls had 
similar numbers of CD4+ or CD8+ T cells with a ―memory‖ like phenotype in the spleen.  
However, the proportion of CD4+ memory-like T cells was significantly increased in athymic 
mice (14 %) compared to sham-operated (11 %) or control (9 %) mice. Likewise, the proportion 
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of CD8+ memory-like T cells was increased in athymic mice (45 %) versus sham-operated 
(25 %) or non-manipulated control mice (19 %).  Since the absolute number of ―memory-like‖ T 
cells is similar in athymic and control mice, the increased proportion of ―memory-like‖ T cells 
brought about by removal of the thymus probably reflects the decrease in the absolute number of 
naïve T cells rather than compensatory proliferation of T cells brought about by removal of the 
thymus.  The apparent lack of compensatory proliferation in athymic mice might partly reflect a 
decrease in IL-7 which is produced by thymic epithelial cells (Alves et al. 2009). 
Because cellular immunity depends in part on the diversity of T cell receptors we analyzed TCR 
diversity in athymic mice and in controls 10 weeks after surgery.  We used a novel approach to 
quantify TCR beta transcript diversity using a real-time polymerase chain reaction (PCR)-based 
method (Wettstein, Strausbauch, Therneau and Borson 2008).  Briefly, the method amplifies 
TCR V beta (β) transcripts using combinations of primers specific for a total of 240 Vβ-Jβ 
combinations.  Cycle threshold (Ct) values were determined for each Vβ-Jβ combination for 
each RNA template and mean Ct values were calculated.  Results shown in Table 7 indicate that 
Ct values did not significantly differ in control (17.8), sham-operated (17.9) or athymic mice 
(18.7) suggesting that removal of the thymus or sham operation did not cause significant 
decrease in TCR diversity or oligoclonal expansions.  These results were supported by Shannon 
entropy calculated for each Vβ-Jβ matrix in each set of mice (Shannon and Warren 1949) 
(Table 7).  An estimate of entropy (H) was calculated by the equation H=Σ (p log 2 p)/log 2 
(1/240) where p was the probability of abundance calculated for each Vβ-Jβ combination by the 
equation p=2−y/Σ2−y where y was the Ct value for each Vβ-Jβ primer pair and p=0 when Ct > 
40 cycles.  Entropy ranges from zero to one with one representing maximal diversity.  Control 
mice had an average entropy of 0.85, sham-operated mice had an average entropy of 0.84 and 
athymic mice had an average entropy of 0.85.  These results agree with values reported for wild-
type repertoires (0.88 on average) and contrast with values obtained in SCID-nude mice (0.76) 
(Dr. Wettstein, personal communication).   
Thymectomy does not impair T cell memory  
To determine whether and how removal of the thymus might impair memory T cell responses we 
used delayed type hypersensitivity (DTH) to ovalbumin as an index.  Figure 13A shows that 
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challenge of athymic mice, produced larger foot-pad swelling than challenge of control mice, 
indicating that removal of the thymus did not impair and may instead enhance memory T cell 
responses.  To determine whether removal of the thymus impairs primary T cell responses and 
test whether memory T cell responses are enhanced in athymic mice, we tested the rate of 
rejection of male to female skin grafts.  Figure 13B shows that removal of the thymus slows the 
kinetics of skin graft rejection in athymic female recipients to male antigens since the median 
survival time of male skin grafts was 37 days in athymic mice and only 25 days in sham-
operated and control mice, respectively.  This result suggests that primary T cell responses were 
impaired.  However T cell memory responses were intact as second set grafts were rejected with 
accelerated kinetics by all recipients, including those lacking the thymus. The results 
demonstrated that generation of T cell memory does not require an intact thymus.  
Removal of the thymus in adult mice does not impair primary or secondary 
antibody responses but increases long-lived antibody secreting cells in the bone 
marrow 
Manifest B cell memory requires antigen specific antibody production at times remote from 
primary antigen stimulation.  At least some B cells engaged in a primary response must survive 
and some must have the ability to respond upon re-exposure.  These antibody responses require 
T cell help (Elgueta et al. 2010).  Whether the thymus is necessary to generate B cell memory 
responses beyond generating a diverse T cell repertoire is not known.  To answer that question 
we tested B cell memory in mice from which the thymus had been removed or manipulated 
without removal 5 weeks before.   
To exclude the possibility that thymectomy imposed a B cell autonomous defect independent of 
T cells we asked whether athymic mice mounted antibody responses to NP-Ficoll, a T-
independent antigen.  Figures 14A and 3B show comparable concentrations of NP-specific IgM 
and IgG3, 21 days following immunization, in athymic mice (230 µg/ml IgM and 64 µg/ml 
IgG3, on average) and sham-operated mice (167 µg/ml IgM and 86 µg/ml IgG3, on average).  
Hence, thymectomy did not perturb T-independent antibody production.  Indeed B cells 
developed normally in mice lacking the thymus compared to sham-operated mice (Figure 15).  





sham-operated or control mice at 5 weeks and at 10 weeks of age, 
respectively.  There were no population unbalances, as the number of marginal zone B cells 
(CD19+ and CD21+) or follicular (CD19+, CD21+ and CD23+) B cells was comparable in 
athymic, sham-operated and control mice.   
A hallmark of B cell memory is the rapid production of high affinity antibodies upon re-exposure 
(Elgueta, de Vries and Noelle 2010).  These properties reflect the survival of fully differentiated 
antigen specific B cells and plasma cells.  To determine whether B cell memory responses were 
impaired in mature athymic mice, we studied responses to immunization with 4-hydroxy-3-
nitrophenyl acetyl (NP), conjugated to ovalbumin.  Figures 16A and 16B show that athymic mice 
produced as much NP-specific IgM or IgG1 as sham-operated mice indicating that removal of 
the thymus did not impair antigen-specific antibody primary or secondary antibody responses to 
vaccination with proteins.  Consistent with that conclusion we found that the number of antibody 
secreting cells present in the bone marrow 6 months after immunization was maintained in sham-
operated mice and increased by 2 fold in athymic mice compared to non-manipulated controls 
(Figure 17).  In fact, since the number of ASC in athymic mice was significantly increased 
compared to the number of ASC in control or sham-operated mice, our results suggest that the 
thymus in the adult may inhibit either the differentiation or the maintenance of long-lived 
antibody secreting cells in the bone marrow.   
Removal or manipulation of the thymus impairs the generation of Ig heavy 
chains associated with high affinity to NP   
The most significant function associated with antibody recall responses is selection of cells 
bearing receptors with increased affinity for the antigen.  To determine if affinity maturation 
requires the integrity of the thymus in the adult, we sampled antibody heavy chain variable 
region nucleotide and protein sequences of IgG1-positive B cells obtained from mice that had 
their thymus removed, manipulated (sham operation) or of non-manipulated controls, 10 days 
following booster immunization.  Sequences were obtained from cloned PCR gene products 
amplified with VH186.2-specific primers (NP selects antibodies encoding the VH186.2 
canonical germline sequence rearranged to DFL16.1 and JH2 (Bothwell et al. 1981)) and C1 
reverse primers in a nested PCR reaction and with Pfu proof-reading polymerase.  Two 
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sequences were obtained per clone and a consensus was generated.  To determine if selection of 
antigen responsive B cells was perturbed in athymic or sham-operated mice we first determined 
the frequency of the VH186.2, DFL16.1 and JH2 joins in all the unique VH186.2 encoding HC 
sequences obtained for each group of mice.  Out of 76 sequences encoding VH186.2 exons 
obtained from athymic mice, 19 had different joins (25 %) and 12 of used DFL16.1 and JH2 
(63 %).  In a total of 70 sequences encoding VH186.2 exons obtained from sham-operated mice, 
37 had different joins (53 %), and 20 used DFL16.1 and JH2 (54 %).  In 48 sequences encoding 
VH186.2 exons obtained from control mice, we found 17 different joins (35 %) and 11 used 
DFL16.1 and JH2 (65 %).  These results suggested that removal of the thymus decreased, while 
sham operation increased, clonal diversity of NP responding B cells in comparison to controls 
even-though the majority of clones encoding the VH186.2 gene segment also encoded DFL16.1 
and JH2 in all the three groups of mice.   
Next we compared the amino-acid sequences of CDR3 regions encoded by each unique join.  
NP-binding antibodies often encode Tyr or Gly at position 95 (Takahashi et al. 1998).  While 
94 % CDR3 joins sequenced from control mice had Y or G at position 95 only 68 % of the 
unique CDR3 joins obtained from sham-operated mice had Y or G at position 95 and 84 % that 
of the unique CDR3 joins sequenced from athymic mice had Y or G at position 95.  These results 
suggest that removal of the thymus and sham operation disturbs selection of NP-reactive clones.  
These results are consistent with defective selection of NP-specific antibodies in sham-operated 
and athymic mice.   
Because defective selection of NP-specific antibodies could result from defective somatic 
hypermutation we measured the mutation frequency of the unique VH gene segments obtained 
from athymic, sham-operated or control mice in relation to the VH186.2 germline sequence.  The 
VH mutation frequencies were 2.6 %, 3 % and 2.3 % in athymic, sham-operated and control 
mice, respectively, suggesting that manipulation or removal of the thymus in the adult did not 
impair somatic hypermutation, per se.  However, the frequency of mutation in the CDR1 region 
of VH186.2 encoding antibodies obtained from control mice was 13.6 % and consisted of very 
focused changes at mostly 3 positions (Figure 18A), but the frequency of mutation in the CDR1 
region of antibodies obtained from athymic and sham-operated mice was only 8.5 % and 7.2 %, 
respectively, and less focused (Figures 18B and 18C).  Decreased frequencies of mutations in the 
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CDR1 regions of the VH186.2 exons in athymic or sham-operated mice compared to CDR1 
sequences obtained from non-manipulated mice suggested a defect in the selection of antigen-
specific antibodies.  In fact, the fraction of sequences containing the W33L NP-affinity 
enhancing mutation was decreased in athymic mice (87 %, figure 19A) and in sham-operated 
mice (21 %, figure 19B), compared to that fraction (98 %) in sequences obtained from control 
mice in which all sequences except for one contained the W33L mutation (Figure 18C).  
Contingency analysis (Chi-square test) revealed the reduction in the number of W33L mutations 
in athymic or sham-operated mice relative to control mice to be significant (p < 0.05, p < 0.0001, 
respectively).  Remarkably, manipulation of the thymus caused a significant reduction in the 
number of the W33L mutations compared to that number in athymic mice (p < 0.0001), 
suggesting that manipulation of the thymus without its removal compromises affinity maturation 
more seriously than its removal.  Because the W33L mutation in the VH186.2 exon by itself 
causes a 10 fold increase on affinity to NP (Allen et al. 1988) the reduction in the frequency of 
the W33L mutation in athymic and in sham-operated mice indicates that the integrity of the 












Specific Aim 1, 2 and 3  
Cell-mediated immunity is thought to depend on the number and
 
the diversity of T cells available 
to respond to an antigenic
 
challenge. Consistent with this concept, decreased numbers of
 
T cells 
and/or contractions of the T cell repertoire are viewed
 
as causing immunodeficiency (O'Keefe et 
al. 2004). Although decreases in the
 
numbers of T cells are clearly associated with 
immunodeficiency,
 
we found that diversity of T cells does not necessarily predict
 
the capacity to 
mount effective cellular immunity. Rather, our
 
results indicate that extensive and homogeneous 
contractions
 
of the TCR repertoire (by over 100-fold) do not preclude normal
 
T cell-mediated 
responses as measured by skin graft rejection,
 
delayed-type hypersensitivity, and host defense.
 
 
The finding that individuals with dramatically contracted diversity
 
of the T cell repertoire (but 
normal numbers of T cells) can
 
have relatively normal cell-mediated immunity is not without
 
precedent. We (Ogle, West, Driscoll, Strome, Razonable, Paya, Cascalho and Platt 2006) have 
found that human subjects who undergo
 
cardiac transplantation in infancy have profound 
contraction
 





age matched controls), but do not suffer
 
a heightened risk of disseminated viral infections or of 
infections
 
with opportunistic organisms or tumors compared with other transplant
 
recipients. In 
the course of cardiac transplantation (or nontransplant
 
cardiac surgery) early in life, the thymus is 
removed and the
 
recipient is treated with Thymoglobulin or anti-CD3 to deplete
 
mature T cells. 
In addition, those patients subjected to thymectomy
 
for nonimmune disease and those who are 
elderly (Goronzy and Weyand 2005; Ogle, West, Driscoll, Strome, Razonable, Paya, Cascalho 
and Platt 2006) do
 
not suffer from the opportunistic infections seen in subjects
 
with DiGeorge 
syndrome or AIDS, conditions associated with defects
 
in TCR diversity (Killian et al. 2004). 
Clearly, a narrow but otherwise unperturbed
 
repertoire of T cells can provide enough host 
defense for an
 
ostensibly normal life. Adaptation of the T cell compartment
 
following 
lymphopenia may in part be contributed by the adoption
 
of "memory-like properties" (Goldrath, 
Bogatzki and Bevan 2000). We would postulate that subjects
 
with DiGeorge syndrome or AIDS 
have impaired host defense not
 




because of nonbalanced lacunae in the TCR repertoire or defects
 
in T cell function that preclude 





The work reported here takes advantage of mice in which contractions
 
of the T cell repertoire are 
secondary to B cell deficiency,
 
lack of B cells, or B cell oligoclonality. To exclude the possibility
 
that our tests of T cell function reflected directly the properties
 
of the B cell compartment, we 
measured T cell functions that
 
are thought to be independent of B cells or Ig — the rejection
 
of 
skin transplants (Cascalho and Platt 2001; Parker, Saadi, Lin, Holzknecht, Bustos and Platt 
1996). Our results showing that QM mice
 
reject MHC-incompatible skin as quickly as wild-type 
mice indicate
 
that the T cells and the lymphoid tissue in these mice are functionally
 
normal, 
although, because of the high frequency of alloreactive
 
T cells ( 3 % in C57BL/6 mice) (Huseby 
et al. 2005), these responses indicate
 
little about the impact of repertoire contractions. In contrast,
 
responses to conventional peptide Ags such as minor histocompatibility
 
Ags or OVA, which are 
thought to depend on responses by relatively
 
rare T cells expressing an Ag-specific TCR 
(Kanagawa, Louis and Cerottini 1982; Lindahl and Wilson 1977; Suchin, Langmuir, Palmer, 
Sayegh, Wells and Turka 2001), were
 
normal in QM mice. These results indicated that that a 
balanced
 





Our results showing that severe contractions of the TCR repertoire
 
do not cause increased 
Pneumocystis load in the lungs of QM
 
compared with wild-type mice are consistent with 
maintained
 
host defense. Because the QM mice have very reduced B cell diversity,
 
a case could 
be made for the lack of specific Abs in the outcome
 
of infection. However, B cell and Ab 
deficiency is thought to
 
cause increased susceptibility to infections by these organisms
 
rather 
than relative resistance. In an exemplary study, Marcotte
 
et al. (Marcotte et al. 1996) reported an 
outbreak of Pneumocystis carinii in
 
µMT mice that have very few B cells owing to a gene-
targeted
 
deletion of the membrane exon of IgM (Kitamura et al. 1991). The authors interpreted
 
these results to indicate that B cells and Abs are important
 
to the clearance of P. carinii. Because 
QM mice can produce
 
Abs against a variety of pathogens (Lopez-Macias et al. 1999) and did 
produce Pneumocystis-specific
 







Our studies raise the possibility that normal host defense might
 
be restored in some conditions by 
promoting the "homeostatic"
 
proliferation of certain clones even if that adaptation does
 
not 
reconstitute repertoire diversity. The T cells resulting
 
from homeostatic proliferation exhibit the 
phenotype and some
 
functions of bona fide memory T cells (Bourgeois et al. 2005; Cho et al. 
2000) and might account
 
for the robust cellular immune responses and host defense in
 
QM mice 
and in subjects thymectomized in infancy (Ogle, West, Driscoll, Strome, Razonable, Paya, 
Cascalho and Platt 2006).
 
 
It is not necessary to invoke memory as the only mechanism of
 
compensation. In favor of 
changes other than memory is the finding
 
that the memory T cells resulting from homeostatic 
proliferation
 
may not survive as long as bona fide memory T cells generated
 
following specific 
Ag stimulation (Bourgeois, Kassiotis and Stockinger 2005) and, thus, be most important
 
when 
the generation of the latter is compromised (Bourgeois, Kassiotis and Stockinger 2005). 
Memory-like
 
T cells may thus work best in infancy before Ag-specific memory
 
T cells have a 
chance to develop (Bourgeois, Kassiotis and Stockinger 2005) and in conditions of B
 
cell 
deficiency that may cause defective Ag-specific T cell
 
memory formation. The normal 
functioning of the T cell compartment
 
in humans and mice with contracted T cell repertoires 
might
 
also reflect the cross-reactivity of TCR or a lesser dependence
 
on peptide specificity than 
is commonly thought. Because memory
 
T cells are functionally more cross-reactive, one may not 
be
 
able distinguish the two. Regardless of what mechanism is eventually
 
proved, our findings 
may inspire the design of therapies aiming
 










Specific aim 4 and 5 
Our results show that the thymus contributes to priming T cell responses (as expected), and to 
affinity maturation of antibodies.  Surprisingly, in spite of compromised selection of B cells 
bearing high affinity B cell receptors, production of long lived antibody secreting cells is not 
defective in athymic or sham-operated mice.  In fact, our results suggest the possibility that the 
thymus may inhibit the generation and/or maintenance of long-lived antibody secreting cells.  
Since removal of the thymus did not critically contract the T cell receptor diversity or decrease 
the number of T cells in a substantive manner, these results suggest that affinity maturation of 
antibodies is critically dependent on the integrity of the thymus.   
Recent studies support the idea that T cell help and the B cell receptor (BCR) strength determine 
B cell fate in response to T-dependent antigen activation.  Thus Paus et al. (Paus et al. 2006) and 
Phan et al.(Phan et al. 2006) suggested that high BCR affinity for antigen dictates differentiation 
to extra-follicular antibody secreting cells causing primary antibody responses.  O’Connor et al. 
(O'Connor et al. 2006) proposed that B cells with a low affinity BCR typically undergo somatic 
hypermutation, while B cells with BCR with moderate affinity for antigen produced mostly long-
lived antibody secreting cells.  BCR affinity and T cell help are interdependent since B cells 
present antigens to T cells following Ig-dependent internalization (Lanzavecchia 1990).  Thus B 
cells that have a competitive advantage to bind antigen owing to higher affinity receptors may 
also better compete for limiting T cell ―help‖ which in turn may determine their fate.  The 
interdependence between BCR affinity and B cell antigen presentation to T cells has made it 
difficult to dissociate the contributions of each to B cell selection and differentiation.  In a ―tour 
de force‖, Victora et al. (Elgueta, de Vries and Noelle 2010) showed that enhancing antigen B 
cell presentation without engaging the BCR promoted migration of B cells from the light zone to 
the dark zone of the germinal center, clonal expansion and plasmablast differentiation.  These 
authors concluded that T cell help limits expansion and differentiation of B cells in the germinal 
center independently of BCR engagement.  However, enhancing B cell antigen presentation by 
germinal center B cells did not induce antibody affinity maturation, suggesting that the combined 
signals provided by BCR ligation and engagement of T cells determine the B cell fate.   
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Our results showing normal or enhanced antibody responses to protein antigens suggested that T 
cell help in athymic or sham-operated mice is adequate to activate and promote differentiation of 
antibody secreting cells short- and long-term.  However since removal or manipulation of the 
thymus compromised affinity maturation of antibodies our results suggest that disruption of 
thymic integrity selectively impairs affinity maturation of antibodies much in the same way as 
enhancing antigen presentation independently of the BCR as reported by Victora et al.(Victora et 
al. 2010).  Because removal of the thymus interrupts the flux of new T cells we considered the 
possibility that the availability of cognate help may be reduced to a greater extent than non-
cognate help, enhancing BCR-independent antigen presentation which in turn would impair 
selection of high affinity B cells.  We propose that absence of optimal cognate T cell help owing 
to interruption of thymic emigration or following manipulation of the thymus abrogates 
competition for B cells expressing B cell receptors with high affinity for antigen randomizing 
differentiation and apoptosis.  Other functions of the thymus such as production of IL7 or 
production of regulatory T cells could also contribute to the regulation of immunity.  We 
observed that removal of the thymus impairs production or maintenance of T regulatory cells 
(Figure 11).  Whether or not decreased production of T regulatory cells in athymic mice 
contributes to defective affinity maturation of antibodies in these mice is not known and this 
question will be an interesting one to resolve.    
Our findings concur with those of Ahuja et al. (Ahuja et al. 2008) who proposed that the long-
lived antibody secreting cell compartment is maintained independently of the memory B cell 
compartment because it does not decline when memory B cells are abrogated.  Our results 
indicate that differentiation of long-lived antibody secreting cells occurs independently of 
affinity maturation that normally accompanies B cell memory responses.  Our work suggests that 
strategies to immunize individuals with congenital or acquired thymic defects (such as following 
cardiac transplantation or cardiac surgery in infancy), or with contracted T cell repertoires (such 
as in aging or after T cell depletion to treat cancer) would benefit from new vaccine designs 









Figure 1. Numbers and TCR V  diversity of splenocytes in C57BL/6, QM, and JH
–/–
 mice. The 
numbers of splenocytes were calculated by multiplying the respective percentage of the total 
events as defined in the flow cytometry dot plot analysis with specific CD4, CD8, and CD19 
mAbs by the total number of white blood cells obtained by counting using a Neubauer counting 
chamber. The number of total splenocytes (average ± SD) was 1.4 x 10
8
 ± 7.3 x 10
7
 in C57BL/6, 
1.1 x 10
8
 ± 5.6 x 10
7
 in QM, and 2.7 x 10
7




 mice. The number of CD3
+
 
splenocytes (average ± SD) was 2.2 x 10
7
 ± 1.5 x 10
7
 in C57BL/6, 1.6 x 10
7
 ± 8.3 x 10
7
 in QM, 
and 6.7 x 10
6




 mice. The number of CD4
+
 splenocytes (average ± SD) was 1.2 
x 10
7
 ± 7.4 x 10
6
 in C57BL/6, 9.4 x 10
6
 ± 4.6 x 10
6
 in QM, and 4.1 x 10
6





The number of CD8
+
 splenocytes (average ± SD) was 5.8 x 10
6
 ± 3.6 x 10
6
 in C57BL/6, 4.8 x 
10
6
 ± 2.5 x 10
6
 in QM, and 2.2 x 10
6




 mice. Asterisks mark statistically 









Figure 2. T cell proliferation assays. CD4
+
 T cells isolated from unmanipulated C57BL/6 (B6), 
QM, or JH
–/–
 mice were cultured on plates coated with anti-CD3 Ab in the concentrations 
indicated (x-axis) and with soluble anti-CD28 Ab (10 µg/ml) (A) or with Con A diluted as 
indicated (x-axis) (B). Proliferation measured at 72 h of culture by (
3
H) thymidine incorporation 







Figure 3. Proliferation assay of in vivo primed T cells. Mice were injected with a 140-µg 
PADRE peptide. Fourteen days later, CD4
+
 T cells purified from the spleen were cocultured with 
mature dendritic cells in the presence of 35 µg/ml PADRE peptide. QM and B6 T cells mounted 
robust proliferation to the PADRE peptide, JH
–/–
 T cells had reduced proliferation (26 % of QM 
or 27 % of B6). Proliferation measured at 72 h of culture by (
3
H) thymidine incorporation is 






FIGURE 4.  
 
Figure 4: Follicular dendritic cell network in lymph nodes. Follicular dendritic cells were 
stained bright fluorescent green and were detected in cryostat sections of lymph nodes stained 
with mAb directed against murine CD21/CD35. H & E-stained sections are shown. Photographs 
are representative of three to four different mice per genotype analyzed. 
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Figure 5: Kaplan Meier survival curves for H-Y-incompatible skin grafts in C57BL/6 (B6), QM, 
and JH
–/–
 mice. The x-axis depicts days following surgery and the y-axis depicts the skin graft 
survival fraction values. Grafts were considered rejected when 90 % or more of the graft lacked 
any viable signs, i.e. hair, pigment, and scale pattern. The median time of rejection was 23 days 
in C57BL/6, 26 days in QM, and 23 days in JH
–/–









FIGURE 6.  
 
 
Figure 6: Delayed-type hypersensitivity assay. We compared delayed-type hypersensitivity 
responses in QM and C57BL/6 (B6) mice. Delayed-type hypersensitivity responses to OVA 
were examined at 24, 36, and 60 h after challenge with 20 µg of OVA (intradermally) in the 
footpads of mice primed 6 days earlier with 100 µg of OVA (s.c). The bars represent the mean 
footpad thickness measured in primed mice minus the mean footpad thickness measured in mice 
injected with PBS and the SD values of the mean; asterisks indicate statistically significant 













Figure 7:  P. murina organismal burden. Pneumocystis murina was isolated from the lungs of 
heavily infected, SCID mice as previously described (Keely, Fischer, Cushion and Stringer 
2004). Inoculation was as described by Shellito et al. (Shellito, Suzara, Blumenfeld, Beck, Steger 
and Ermak 1990). The number of P. murina genomes was determined by real time RT-PCR in 
lung tissue of mice infected 2 wk earlier or of mice treated with PBS. Quantitative RT-PCR to 
enumerate Pneumocystis was performed using the Bio-Rad iCycler system, SYBR Green 
detection software, and primers targeting the Pneumocystis large mitochondrial subunit (Shellito, 
Suzara, Blumenfeld, Beck, Steger and Ermak 1990). Amplifications of unknown samples were 
compared with plasmid standards containing mouse Pneumocystis-specific mitochondrial DNA. 
The bars represent the SD values of the mean and the numbers above refer to the number of mice 











Figure 8: Spectratyping analysis of the V  repertoire of C57BL/6 and JH
–/–
 splenocytes. Shown 
are the spectra of CDR3 length distribution corresponding to the families V 4, V 8.2, and V 12, 






















Figure 9: Numbers of "memory-like" CD4-positive or CD8-positive T cells in the spleens of 
C57BL/6 (B6), QM or JH
–/–











 by FACS analysis. In the graph the height of the bar represents the 
average of each distribution. All of the mice were between 13 and 15 wk of age. Significant 













FIGURE 10.  
 
Figure 10: Measurement of T cell receptor (TCR) excision circles (TREC). Figure depicts the 
number of TRECs per 100 nanogram (ng) of genomic DNA in mice lacking the thymus (T), 5 
weeks after surgery, and in age matched controls (C) by real time PCR. Control mice had an 
average of 721 TRECs per 100 ng of DNA while mice lacking the thymus had less than 117 per 
100 ng DNA which is the detection limit of the assay. The two groups differed significantly by 









   
Figure 11: Number of CD4+, CD25+, Foxp3+ (Treg) cells in the spleens of athymic (T), sham-
operated (S) or non-manipulated control (C) mice, 5 weeks and 10 weeks after surgery.  
Numbers were calculated by multiplying the respective percentage as defined in a flow 
cytometry dot plot analysis with specific CD4, CD25 and Foxp3 monoclonal antibodies, by the 
total number of white blood cells (WBC). Groups compared by T test analysis. Statistically 

















































































































































Figure 12:  Number of lymphocytes in spleens harvested from mice lacking the thymus, 
sham-operated or non-manipulated controls at 5 and at 10 weeks of age.  Thymectomies 
were performed 2 days before the mice turned 5 weeks old.  Numbers of lymphocytes were 
calculated by multiplying the respective percentage as defined in a flow cytometry dot plot 
analysis, with specific monoclonal antibodies, by the total number of white blood cells (WBC) in 
athymic (T), sham-operated (S) or unmanipulated control (C) mice at 5 and 10 weeks (W) after 
surgery. (A) Number of CD4+ splenocytes or, (B) Number of CD8+ splenocytes. (C, D) Number 




)/CD44hi/CD62L- by FACS 
analysis.  In the graphs, the bar represents the average of each distribution.  Means were 
compared by a paired two-tailed T test.  Statistically significant differences are denoted by an 




FIGURE 13.  
 
 
Figure 13:  Primary cellular immune responses are delayed in mice lacking the thymus but 
T cell memory responses are maintained. Affinity maturation of antibodies requires 
integrity of the adult thymus  (A) Delayed Type Hypersensitivity (DTH) responses to 
ovalbumin in control (C), sham-operated (S) or athymic (T) mice.  DTH responses to intradermic 
injection of 20 μg ovalbumin were examined in the footpad of mice 6 days after priming by 
subcutaneous injection with 100 μg of ovalbumin (priming) or PBS (control).  Footpad swelling 
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measured in mm is indicated on the y-axis.  Mice lacking the thymus produced significantly 
larger swelling (15 mm, on average) in response to challenge than sham-operated mice (6.0 mm, 
on average) or control mice (6.5 mm, on average).  Footpad swelling was compared by a paired 
two-tailed T test. 
(B) Kaplan Meier survival curves for H-Y incompatible skin grafts in athymic (T), sham-
operated (S) or control (C) mice.  X-axis, days following surgery; y-axis, skin graft survival 
fraction.  Grafts were considered rejected when 90 % or more of the graft lacked any viable 
signs: hair, pigment and scale pattern.  The median survival time of first set grafts was 25 days in 
control mice, 25 days in sham-operated mice and 37 days in mice lacking the thymus.  Skin graft 
rejection by athymic mice was significantly delayed compared to rejection in controls (p=0.0052, 
log-rank, Mantel-Cox test).  Secondary transplants were done 8 to 12 weeks after rejection of the 
first transplant.  The median survival time of initial transplants was 15 days in control mice, 16 
days in sham-operated mice and 19 days in athymic mice.  Secondary graft survival in athymic 
















Figure 14:  T-independent antibody responses maintained in athymic mice.  (A, B) T-
independent antibody responses to NP-Ficoll in athymic mice (T) or in sham-operated (S) mice.  
Figures 3A and 3B represent the concentrations of NP-specific IgM (A) or NP-specific IgG3 (B), 
in µg/ml (y-axis) prior to and 21 days after immunization.  Mice lacking the thymus and sham-
operated mice had on average 4.0 µg/ml and 5.0 µg/ml NP-specific IgM respectively, and non-
detectable NP-specific IgG3, prior to immunization.  Athymic and sham-operated mice had 
230µg/ml and 167µg/ml NP-specific IgM, on average, 21 days after immunization, respectively.  
Mice lacking the thymus and sham-operated mice had on average 64µg/ml and 86 µg/ml NP-
specific IgG3, 21 days after immunization, respectively.  The concentrations of NP-specific IgM 









FIGURE 15.  
 
Figure 15: Number of B cells in the spleens of athymic (T), sham-operated (S) or non-
manipulated control (C) mice, 5 weeks and 10 weeks after surgery.  
Numbers were calculated by multiplying the respective percentage as defined in a flow 
cytometry dot plot analysis with specific CD19, CD21 and CD23 monoclonal antibodies, by the 
total number of white blood cells (WBC). No significant differences were found between groups 













Figure 16:  Removal of the thymus or sham operation maintained IgG1 specific antibody 
responses (A, B) T-dependent responses to NP-ovalbumin.  Figures 4A and 4B represent the 
concentrations of NP-specific IgM or NP-specific IgG1, in µg/ml (y-axis) prior to (PI) and the 21 
days after primary (D21) or booster immunization (21PB), respectively.  (A) Athymic mice (T) 
and sham-operated mice (S) had an average of 8.4µg/ml and 4.4µg/ml NP-specific IgM, prior to 
immunization (PI), 76 µg/ml and 111µg/ml, 21 days after immunization (D21), 293 µg/ml and 
296 µg/ml 21 days after boosting (21PB), respectively.  There were no significant differences 
between athymic and sham-operated mice.  (B) Mice lacking the thymus or sham-operated mice 
had no detectable NP-specific IgG1 prior to immunization, but produced on average, 121µg/ml 
and 231µg/ml NP-specific IgG1 21 days after immunization, 596 µg/ml and 622 µg/ml 21 days 
after boosting, respectively.  T test analysis revealed no significant differences between athymic 









Figure 17:  Number of NP-specific IgG1 antibody secreting cells (ASC) in the bone marrow 
of mice lacking the thymus or control mice, 6 months after boost immunization.  Mice 
lacking the thymus (T) had on average 198 ASC per 10
6
 B cells while sham-operated mice (S) 
had an average of 113 ASC per 10
6
 B cells and, control mice (C) had an average of 100 ASC per 
10
6
 B cells NP-specific IgG1 antibody secreting cells in the bone marrow.  The number of ASC 
in athymic mice was significantly increased compared to the number of ASC in control 
(P=0.0042) or sham-operated mice (P=0.0075) (unpaired T test). The number of ASCs was 












Figure 18: Heavy chain VH 
CDR1 and CDR 2 DNA 
sequences of IgG1-B cells 
obtained from the spleen of 
mice lacking the thymus (T), 
sham-operated (S) or control 
(C) mice, 10 days following 
boost immunization.   
Figures show the CDR1 or CDR2 
sequences of all the distinct VH 
sequences aligned to the germline 
VH186.2 segments.  Shadowed 
are CDR1 and CDR2 regions.  
(A) Sequences obtained from 
control non-manipulated mice; 
(B) Sequences obtained from 
athymic mice;  








Figure 19: Heavy chain VH 
amino-acid sequences of 
IgG1-B cells obtained from 
the spleen of mice lacking 
the thymus (A), sham-
operated (B) or control (C) 
mice, 10 days following 
boost immunization.   
Figures show the aligned 
translation of all the distinct 
VH186.2 segments obtained 
from each group of mice.  
Shadowed are CDR1 and 
CDR2 regions and in a darker 
grey shade residue #33 is 
indicated.  Antibodies with 
high affinity to NP often 
encode a W to L mutation in 






Table 1. Median rejection times for H-Y- and MHC-incompatible mice  
 
H-Y-Incompatible Mice Median Rejection 
Times 
MHC-Incompatible Mice Median 
Rejection Times 
 
C57BL/6 23 (n = 12; 15, 15, 17, 17, 18, 23, 23, 23, 
24, 25, 33, 36) 
13 (n = 3; 13, 13, 13) 
QM 26 (n = 13; 12, 12, 12, 14, 17, 26, 26, 26, 
32, 32, 32, 34, 39) 
11 (n = 4; 11, 11, 12, 13) 
JH
–/–






















Table 2. Median rejection times for first and second transplants  
 
First Transplant Median Rejection 
Times (days) 
Second Transplant Median Rejection 
Times (days) 
 
C57BL/6 17 13 
C57BL/6 24 15 
C57BL/6 24 15 
QM 32 13 
QM 32 16 
QM 32 20 
QM 26 15 
QM 26 16 

















Table 3. Sequences obtained by PCR amplification of cDNA obtained from one C57BL/6   
Spleen. 
a
 Sequences were aligned using the software provided by the IMGT server (Bosc and 
Lefranc 2000; Giudicelli, Chaume and Lefranc 2005). 
TCR 
V 13-3 V Region N1/P1 D Region N2/P2 J Region 
 
C57.17 GCCAGCAGTGA  AGGGGG  AGAAGTCTTCTTT 
C57.19 GCCAGCAGTG  GGACAGGGG C CACAGAAGTCTTCTTT 
C57.6 GCCAGCAG CGTA GGGAC GGC TTCTGGAAATACGCTCTATTTT 
C57.50 GCCAGCAGTGAT CCCGGC GGGG A TTCTGGAAATACGCTCTATTTT 
C57.39 GCCAGC G TGGG  TTCTGGAAATACGCTCTATTTT 
C57.22 GCCAGCAGT C CAGGGG C CGAAAGATTATTTTTC 
C57.24 GCCAGCAG AA GGACAG A TAACAACCAGGCTCCGCTTTTT 
C57.1 GCCAGCAGTGAT CGGC   ACCAGGCTCCGCTTTTT 
C57.29 GCCAGCAGT CCC GGGACAGGGGG AAGG TCGCCCCTCTACTTT 
C57.5 GCCAGCAGTG GGGA   TAACTATGCTGAGCAGTTCTTC 
C57.36 GCCAGCAGTGATG GGGC   TGCTGAGCAGTTCTTC 
C57.37 GCCAGCAGTGATG CG CAGGGGGC T TATGCTGAGCAGTTCTTC 
C57.18 GCCAGCAGTGATG CAAG GGGACTGGGGGG CCCC TAACTATGCTGAGCAGTTCTTC 
C57.28 GCCAGCAGT CC GGACTGGGGGG A TAACTATGCTGAGCAGTTCTTC 
C57.8 GCCAGC  GGGGGGC T TGCAGAAACGCTGTATTTT 





GCCAGCAG CA ACAGGGGG GGAGAAG ACACCTTGTACTTT 
C57.12 GCCAGCAGTGA GG CAGGGGG  CACCTTGTACTTT 





GCCAGCAGTGAT  CTGGGG AGG CAAAACACCTTGTACTTT 
C57.3 GCCAGCAG  GGACTGGGGG CCT AGTCAAAACACCTTGTACTTT 
75 
 
C57.21,46 GCCAGCAGTGA AGC GGGGGGGC GC AACACCTTGTACTTT 
C57.11 GCCAGCA A GGACA TA CAAGACACCCAGTACTTT 
C57.13 GCCAGCAGTGAT CC GGGACA A CAAGACACCCAGTACTTT 
C57.26 GCCAGCAGTGA CGC GGACA T CCAAGACACCCAGTACTTT 
C57.4,23 GCCAGCAGTG  GGACAGGG AGGGG TGAACAGTACTTC 
C57.49 GCCAGC  GGACAGG TTC CCTATGAACAGTACTTC 
C57.32 GCCAGCAGT  CTGGGGGGGC GA GAACAGTACTTC 


























Table 4. Sequences obtained by PCR amplification of cDNA obtained from one QM spleen
a
 
TCR V 13-3 V Region N1/P1 D Region N2/P2 J Region 
 
QM.6 GCCAGCAGTGAT CC GGGA TTGG ACACAGAAGTCTTCTTT 
QM.16,37 GCCAGCAGTGATG  GGGAC GG GAACACAGAAGTCTTCTTT 
QM.18 GCCAGC GGAGGG CAGGGG C CAGAAGTCTTCTTT 
QM.50 GCCAGCAG  GGACAGGGGGC CCC CAGAAGTCTTCTTT 
QM.19 GCCAGCAGTG   TTCCAGAG GTCTTCTTT 
QM.57 GCCAGCAGTGAT TCCGGAAT   CACAGAAGTCTTCTTT 
QM.58 GCCAGCA AAG   CAAACACAGAAGTCTTCTTT 
QM.8 GCCAGCAGTGATG  GGGACAGGG C CTCCGACTACACCTTC 
QM.38 GCCAGCAGTG GG CAGG CGC ACTCCGACTACACCTTC 
QM.40 GCCAGCAGT TGG CAGGGG AC CTCCGACTACACCTTC 
QM.21 GCCAGCAGTGA AG AGGGGG  CTGGAAATACGCTCTATTTT 
QM.53 GCCAGCAGTGATG  GGACAGGG CC TTCTGGAAATACGCTCTATTTT 
QM.2 GCCAGCA AGGGA GGGAC C TCCAACGAAAGATTATTTTTC 
QM.9,10 GCCAGCAGTGA CC GGGACA A TTCCAACGAAAGATTATTTTTC 
QM.24 GCCAGCAGTGATG  GGGGC G CCAACGAAAGATTATTTTTC 
QM.27 GCCAGCAGTGATG  ACAGGGGGC GGGT CAACGAAAGATTATTTTTC 
QM.29 GCCAGCAGTGA  CAGGG  ACAACCAGGCTCCGCTTTTT 
QM.11 GCCAGCAGTGAT   AGACG CAACCAGGCTCCGCTTTTT 
QM.3 GCCAGCAG GGCGACGG   CCTATAATTCGCCCCTCTACTTT 
QM.5 GCCAGCAGTGATG   ACAA TTCCTATAATTCGCCCCTCTACTTT 
QM.14 GCCAGCAGTG   CCGG TTCCTATAATTCGCCCCTCTACTTT 
QM.31 GCCAGCAGTGA   CA ATAATTCGCCCCTCTACTTT 
QM.4 GCCAGCAGTGATG CACCCTCT CTGGG TT CTATGCTGAGCAGTTCTTC 
QM.44 GCCAGCAGTG  GGGACTGGGGG CTA TATGCTGAGCAGTTCTTC 
QM.46 GCCAGCAGTGAT AAC CTGGGGGGG TCT TATGCTGAGCAGTTCTTC 
QM.7 GCCAGCAGTGAT   CTCGGG AACTATGCTGAGCAGTTCTTC 
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QM.42 GCCAGCAGTGATG  CAGGGGG  CACCGGGCAGCTCTACTTT 
QM.48 GCCAGCAGTG  GGACAGGGG  ACACCGGGCAGCTCTACTTT 
QM.43 GCCAGCAGTGAT T TGGGGG  ACACCGGGCAGCTCTACTTT 
QM.51 GCCAGCAGT AC GACTGGGGGGGC GCC CACCGGGCAGCTCTACTTT 
QM.33 GCCAGCAGTGA  GAACAA  AAACACCGGGCAGCTCTACTTT 
QM.17 GCCAGCAGTG  GGACA CAG GCAGAAACGCTGTATTTT 
QM.13 GCCAGCAG CCCT GGACTGGGGG  ACACCTTGTACTTT 
  QM.20 GCCAGCAGTGATG  TGGGGGGG  CAAAACACCTTGTACTTT 
QM.22 GCCAGCAG GG CTGG  AGACACCCAGTACTTT 
QM.15 GCCAGCAGTGAT C CAGGGG AC GAACAGTACTTC 
QM.23 GCCAGCAGTGA GA GGGACAGGG AT TATGAACAGTACTTC 
QM.30 GCCAGCAGTGATG T ACAG  TATGAACAGTACTTC 
QM.36 GCCAGCAGTGA  CAGGG CT TATGAACAGTACTTC 
QM.1 GCCAGCAGTGAT CCC GACTGGGGG AG CTCCTATGAACAGTACTTC 
QM.28 GCCAGC    TATGAACAGTACTTC 
QM.39 GCCAGCAGTGATG GGG   CCTATGAACAGTACTTC 
QM.45 GCCAGCAGTG GG   CTATGAACAGTACTTC 
 
a
 Sequences were aligned using the software provided by the IMGT server (Bosc and Lefranc 


















 Sequences were aligned using the software provided by the IMGT server. 
TCR V 13-3 V Region N1/P1 D Region N2/P2 J Region 
 
JH.18 GCCAGCAGTGA  GACAGGG  GAAGTCTTCTTT 
JH.63 GCCAGC GGAGGG CAGGGG C CAGAAGTCTTCTTT 
JH.46 GCCAGCAGTGATG  TGGG  CAAACACAGAAGTCTTCTTT 
JH.5,19 GCCAGCAGTGA  GACAGGGGGC  AACTCCGACTACACCTTC 
JH.30 GCCAGCAGTGAT  CTGGGGGGGC CGT ACACCCAGTACTTT 
JH.29 GCCAGCAGTGA G AGGG T TTCTGGAAATACGCTCTATTTT 
JH.35 GCCAGCAGTG G GGGACA AAA TTCTGGAAATACGCTCTATTTT 
JH.50 GCCAGCAGTG GC GGGACA AA TTCTGGAAATACGCTCTATTTT 
JH.60 GCCAGCAGTGA AT GGACAGGGG  CTGGAAATACGCTCTATTTT 
JH.43 GCCAGCAGTGA   CAA TTCTGGAAATACGCTCTATTTT 
JH.62 GCCAGCAGTGA CAA   TTCTGGAAATACGCTCTATTTT 
JH.9,10 GCCAGCA CC GACAGGGG AC CCAACGAAAGATTATTTTTC 
JH.32 GCCAGCA TCC GGGA TA TTTCCAACGAAAGATTATTTTTC 
JH.45 GCCAGCAGTGATG CGTGGT   TTTCCAACGAAAGATTATTTTTC 
JH.71 GCCAGCAGCC   CCCGGCATC TTTCCAACGAAAGATTATTTTTC 
JH.51 GCCAGCAG  GGGA AT CAACCAGGCTCCGCTTTTT 
JH.41 GCCAGCAGTGATG   CACGG AACAACCAGGCTCCGCTTTTT 
JH.6 GCCAGCAGTGATG CTC GGGGGC GGGTC GCTGAGCAGTTCTTC 
JH.67 GCCAGCAGTG TCC GGGACTGGGGGGGC  GCTGAGCAGTTCTTC 
JH.3 GCCAGCAGTGA AGAC   AACTATGCTGAGCAGTTCTTC 
JH.20,22 GCCAGCAG GT GGGACAG AG ACACCGGGCAGCTCTACTTT 
JH.48,54 GCCAGCAGTGAT  CACCGGGC GGT CACCGGGCAGCTCTACTTT 
JH.36 GCCAGCAGTGATG  GGGGGG A AAACACCGGGCAGCTCTACTTT 
JH.66,68,72 GCCAGCAG CCTCGC GGGGGG T AACACCGGGCAGCTCTACTTT 
JH.4 GCCAGCAGTGATG CCA   CAAACACCGGGCAGCTCTACTTT 
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JH.47 GCCAGCAGTGAT C GGGGGGGC GC TGCAGAAACGCTGTATTTT 
JH.27,55 GCCAGCAGT CCTGAC GGGGGC G GTCAAAACACCTTGTACTTT 
JH.42 GCCAGCAGTGATG  ACAGGGG AG CCTTGTACTTT 
JH.59 GCCAGCAG CC GGGACA AC CAAAACACCTTGTACTTT 
JH.34 GCCAGCAG GTC ACTGGGGGGGC GGC CAAAACACCTTGTACTTT 
JH.39 GCCAGCAGT TT ACTGGGGGGGC GGGGG CAAAACACCTTGTACTTT 
JH.70 GCCAGCAG  CTGGGGGGG G AGTCAAAACACCTTGTACTTT 
JH.38 GCCAGCAGTG   GAGGT AGTCAAAACACCTTGTACTTT 
JH.25 GCCAGCAGTGA  CAGG CCCTT CCAAGACACCCAGTACTTT 
JH.21 GCCAGCAG  GGACA AACT CCAAGACACCCAGTACTTT 
JH.44 GCCAGCAGTGATG TC GGGACAGGGGGC CGG GACACCCAGTACTTT 
JH.57 GCCAGCAGTGA  CAGGGG  CCAAGACACCCAGTACTTT 
JH.31 GCCAGCAGTGA  GACAGGGGGC  AACTCCGACTACACCTTC 
JH.37 GCCAGCAGT AACAGGGC CTGGGGGGGC G ACCAAGACACCCAGTACTTT 
JH.40 GCCAGCAGTGATG  GGACTGGGGG T AACCAAGACACCCAGTACTTT 
JH.56 GCCAGCAGT C GACTGGG T CAAGACACCCAGTACTTT 
JH.23 GCCAGCAG  GACTGGGGGGG G CTATGAACAGTACTTC 
JH.33 GCCAGCAGT CCC GGGACAGGGGG  CTCCTATGAACAGTACTTC 
JH.49 GCCAGCAGT TT GGACAGGGG A GAACAGTACTTC 
JH.52 GCCAGCAGT ACC GGGACA  TCCTATGAACAGTACTTC 
JH.61 GCCAGCAGTGATG  GGGGG TC CTCCTATGAACAGTACTTC 
JH.64 GCCAGCAGTG G AGGG  GAACAGTACTTC 
JH.65 GCCAGCAGTGATG  ACAG  CTATGAACAGTACTTC 
JH.1,15 GCCAGCAGTG  GGACTGGGGGG  TATGAACAGTACTTC 
JH.7,8,11,12,14,16 GCCAGCAGTGA CCTC GGGACTGGGGGG  TCCTATGAACAGTACTTC 
JH.13 GCCAGCAG A GGGGGGC C CTCCTATGAACAGTACTTC 
JH.24 GCCAGCAGTGATG ACAG   CTATGAACAGTACTTC 
JH.26 GCCAGCAGTGATG CCCTTTC ACTGGGGGG  CTCCTATGAACAGTACTTC 





Table 5. (B) The number of V 13-3 sequences containing each J  per strain
a
 




J1-1 2 7 4 
J1-2 0 3 3 
J1-3 3 2 6 
J1-4 1 4 5 
J1-5 2 2 2 
J1-6 1 4 0 
J1-7 5 0 0 
J2-1 0 4 3 
J2-2 0 5 9 
J2-3 2 6 1 
J2-4 14 2 8 
J2-5 3 1 8 
J2-7 5 8 9 
 
a
 Sequences were aligned using the software provided by the IMGT server (Bosc and Lefranc 








Table 6. Numbers of lymphocytes in the spleen of athymic (T), sham-operated (S) or non-









 5 Weeks 10 Weeks 
Number 
(average ± SD) 
T S C T S C 
CD4+ 4.77 x 106 ± 
0.85 x 106 
7.92 x 106 ± 
0.82 x 106 
8.37 x 106 ± 
1.73 x 106 
3.6 x 106 ± 
0.97 x 106 
8.8 x 106 ± 
2.96 x 106 
10.1 x 106 ± 
1.78 x 106 
CD8+ 2.42 x 106 ± 
0.47 x 106 
4.32 x 106 ± 
0.41 x 106 
2.59 x 106 ± 
0.39 x 106 
2.52 x 106 ± 
0.72 x 106 
5.74 x 106 ± 
2.14 x 106 
7.68 x 106 ± 
2.55 x 106 
CD4+ 
CD44hiCD62L- 
1.3 x 106 ± 
0.1 x 106 
1.4 x 106 ± 
0.4 x 106 
1.7 x 106 ± 
0.45 x 106 
1.04 x 106 ± 
0.44 x 106 
1.6 x 106 ± 
0.53 x 106 
1.2 x 106 ± 
0.23 x 106 
CD8+ 
CD44hiCD62L- 
0.74 x 106 ± 
0.05 x 106 
0.94 x 106 ± 
0.3 x 106 
1.1 x 106 ± 
0.26 x 106 
1.15 x 106 ± 
0.46 x 106 
1.44 x 106 ± 
0.3 x 106 
1.5 x 106 ± 
0.34 x 106 
CD19+CD21+CD23- 1.29 x 106 ± 
0.32 x 106 
1.36 x 106 ± 
0.45 x 106 
1.53 x 106 ± 
0.3 x 106 
4.3 x 106 ± 
2.5 x 106 
3.6 x 106 ± 
01.1 x 106 
5.93 x 106 ± 
1.6 x 106 
CD19+CD21+CD23+ 21.59 x 106 ± 
2.11 x 106 
20.50 x 106 ± 
3.89 x 106 
24.32 x 106 ± 
4.9 x 106 
27.31 x 106 ± 
11.33 x 106 
24.49 x 106 ± 
6.9 x 106 
25.12 x 106 ± 
5.7 x 106 
82 
 
Table 7. Cycle threshold values (Ct values) were estimated for all Vβ-Jβ combinations for each 
RNA template and mean Ct values were calculated.  Ninety-five percent confidence intervals 
(CI) are shown.  Diversities of expressed Vβ-Jβ pairs were calculated with Shannon entropy 
(86).  An estimate of scaled entropy (H) was calculated for each Vβ-Jβ matrix by the equation 
H=Σ (p log 2 p)/log 2 (1/240) where p was the probability of abundance calculated for each Vβ-
Jβ combination by the equation p=2−y/Σ2−y where y was the Ct value for the Vβ-Jβ primer pair 
and p=0 when Ct > 40 cycles.  Scaled entropy ranges from zero to one with one representing 
maximal diversity.  
T=athymic mice, S=sham-operated mice, C=non-manipulated mice 
Sample Entropy Mean Ct 95 % CI 
C-spleen #1 0.85 17.4 17.1-17.4 
C-spleen #2 0.84 18.1 17.8-18.4 
S-spleen #1 0.83 18.0 17.7-18.4 
S-spleen #2 0.84 17.8 17.4-18.2 
T-spleen #1 0.84 18.8 18.4-19.1 












Table 8: Analysis of Vh186.2 Somatic mutation in NP-immunized mice. Expressed sequences 
from twice boosted Controls, sham and thymectomized mice were analyzed. The Vh186.2 
Sequences were 294 bp that translate to 98 AA. We found that thymectomized mice do have 
somatic mutation frequency as wild type but have reduced frequency of affinity enhancing 
mutation at codon 33 of DR1.Also thymectomized mice showed higher frequency of repeated 
























Tx 2nd  Tx Difference 
Control 1 23 12 11 Sham 1 22 13 9 Thymectomized 1 27 19 8 
Control 2 25 15 10 Sham 2 24 16 8 Thymectomized 2 33 21 12 
Control 3 25 16 9 Sham 3 25 16 9 Thymectomized 3 45 17 28 
Control 4 25 16 9 Sham 4 28 20 8 Thymectomized 4 48 19 29 
Control 5 27 13 14 Sham 5 29 14 15 Thymectomized 5 37 18 19 
Mean 25 14.4 10.6 Mean 25.6 15.8 9.8 Mean 38 18.8 19.2 
 










Proportion of (C-> T 
or G->A) Mutation 
Control 80 21 489 2.819 % 34.56 % 
Thymectomized 86 62 196 2.778 % 37.24 % 













Control 77 20 336 6.02 % 80.702 % 
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SUMMARY AND CONCLUSION  
In summary after our lab found that TCR diversification in the thymus depends on B cell 
receptor or immunoglobulin (Ig) diversity we also found that B cells help maintain the number 
and diversity of T cells in the peripheral T cell compartment. In this work we determined the 
extent to which thymus output of T cell, peripheral survival or proliferation maintain the size and 
diversity of the T cell compartment and how it adapts to contraction of T cell diversity.  
We also found that when T cell diversity is contracted, T cells commonly exhibit a "memory-
like" phenotype of unknown functional significance.  
In our study we also investigated mice with severe contraction of T cell diversity and their 
response to pathogenic microorganisms or if they suffered increased susceptibility to auto-
immunity. We described how mice respond to thymectomy and determined if thymectomy 
perturbed the T and B cell compartments. We also specifically studied if B cell memory is 
maintained following thymectomy in young mice  
B cell memory antibody responses critically depend on T cell help.  To determine the extent to 
which T cell function was maintained in thymectomized mice we performed male to female skin 
grafts.  The median survival time of male skin grafts was 37 days in thymectomized female mice 
and only 25 days in sham operated and control mice. Thus, thymectomy impairs cellular 
immunity to minor antigens. Re-transplant 30 days after shedding of the primary graft, hastened 
graft rejection in all mice even though thymectomized recipients had delayed graft rejection 
compared to controls. Accelerated secondary graft rejection indicates efficient generation of T 
cell memory.  
To determine whether thymectomy perturbed primed T cell responses we tested delayed type 
hypersensitivity (DTH) to ovalbumin in the footpad of mice. After priming by subcutaneous 
injection of 100 micrograms of ovalbumin in PBS, thymectomized mice mounted a significant 
DTH response to the challenge comparable to the responses in sham operated and control mice.  




One hallmark of memory is the production and maintenance of long-lived plasma cells capable 
of maintaining serum specific antibodies for very long periods of time following last exposure to 
the antigen.   If  thymectomy impairs B cell memory, the number of long lived antibody 
secreting cells (ASC) should be reduced at times remote from antigenic exposure.  We 
determined the number of NP-specific antibody secreting cells in the spleen or in the bone 
marrow 6 months after boosting thymectomized, sham operated or control C57BL/6.  
In our conclusion we found that manipulation of the thymus may perturb affinity maturation in 
sham operated mice. 
Thymectomy impairs primary T cell responses while sustaining ―normal‖ T cell memory and 
primed responses as depicted by delayed primary male to female skin graft rejection and faster 
secondary skin graft rejection and normal DTH responses.  Surprisingly despite impairing 
primary T responses, thymectomy appears to enhance B cell memory.    Enhanced B cell 
memory in the presence of certain T cell dysfunctions suggests dissociation between T cell help 
requirements to generate B cell memory and those required to generate primary T cell responses. 
We will also consider the possibility that T cell regulation of B cell memory is altered by 
thymectomy. 
Our findings propose that the long-lived antibody secreting cell compartment is maintained 
independently of the memory B cell compartment because it does not decline when memory B 
cells are abrogated.  Our results indicate that differentiation of long-lived antibody secreting cells 
occurs independently of affinity maturation that normally accompanies B cell memory responses.  
Our work suggests that strategies to immunize individuals with congenital or acquired thymic 
defects (such as following cardiac transplantation or cardiac surgery in infancy), or with 
contracted T cell repertoires (such as in aging or after T cell depletion to treat cancer) would 
benefit from new vaccine designs including surrogates of cognate T cell help. 
Specific aim 1, 2 and 3 were published in Journal of Immunology, in print Volume 178, Issue 
5, pages 2950–2960, Mar 1, 2007  
Specific aim 4 and 5 were published in European Journal of Immunology, online: 27 Dec 2011, 
in print Volume 42, Issue 2, pages 500–510, February 2012 
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